Amniotic Fluid Embolism

Complex MONDO:0850046 Pathograph 24 Show in embeddings browser Pregnancy disorder Obstetric emergency Peripartum cardiovascular collapse

Amniotic fluid embolism is a sudden, catastrophic peripartum syndrome of cardiovascular collapse, hypoxaemia and coagulopathy that begins when the physiological barrier separating the fetal and maternal compartments is breached during labour, delivery or the immediate postpartum period. It is named for a mechanism it largely does not have. The historical account was mechanical - fetal squames, lanugo and vernix physically obstructing the maternal pulmonary microvasculature - but the national registry analysis that first characterised the syndrome systematically found its clinical and haemodynamic picture indistinguishable from anaphylaxis and septic shock, and concluded that the name is a misnomer. The dominant modern account is an abnormal maternal humoral response to fetal tissue exposure, with proinflammatory mediator activation resembling the systemic inflammatory response syndrome. Whatever initiates it, the haemodynamic sequence is stereotyped and ordered: pulmonary vasoconstriction raises pulmonary vascular resistance, the right ventricle fails acutely, and left ventricular dysfunction and systemic collapse follow. That ordering is a management decision rather than an academic one, because a failing right ventricle is treated with inotropes, pulmonary vasodilators and vasopressors rather than with volume. The coagulopathy is the part of this entry that is mechanistically distinctive rather than merely severe. Coagulation is activated and fibrinogen consumed, as in any disseminated intravascular coagulation - but in a direct comparison against severe placental abruption, fibrinolytic activation in amniotic fluid embolism was hyperactive and uncoupled from coagulation activation, with raised tissue plasminogen activator and depleted thrombin-activatable fibrinolysis inhibitor. Bedside series show the same signature from the other direction: fibrinogen and factor V disproportionately low and D-dimers exorbitant while platelets and antithrombin are only slightly reduced. The clinical expression is therefore haemorrhage, not occlusive thrombosis, which is why this entry claims module conformance for coagulation activation but deliberately not for thrombus formation. Two facts constrain everything above. There is no diagnostic test - amniotic fluid embolism remains a clinical diagnosis and no candidate biomarker has proved reliable - so the case definition itself is a moving quantity, and registries using expert chart review report systematically different incidence and mortality from administrative-database studies. And there is no disease-modifying therapy: every established intervention is supportive resuscitation, haemostatic replacement and prompt delivery.

Ask OpenScientist

Ask a research question about Amniotic Fluid Embolism. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

◈

Mechanistic Hypotheses

Abnormal maternal humoral/anaphylactoid response to fetal antigen exposure

anaphylactoid_immune_response CANONICAL

Evidence balance 4 support

Under this model the injury is caused not by the physical presence of fetal material but by the maternal reaction to it. Fetal antigens entering the maternal circulation trigger proinflammatory mediator release resembling the systemic inflammatory response syndrome, with complement activation and kallikrein-kinin and coagulofibrinolytic involvement, in a susceptible host. The supporting arguments are the haemodynamic identity with anaphylaxis and septic shock, the excess of atopy among cases, and the measurable consumption of complement components and C1 esterase inhibitor. The model is explicitly non-IgE-mediated, which is why "anaphylactoid" rather than "anaphylactic" is the term used.

Pathograph links

Entry of Amniotic Fluid and Fetal Antigens into the Maternal Circulation -> Abnormal Maternal Proinflammatory Mediator Activation DIRECT Under the canonical model the fetal antigen load provokes a systemic humoral response rather than acting mechanically.

Abnormal Maternal Proinflammatory Mediator Activation -> Complement Activation and C1 Esterase Inhibitor Consumption DIRECT Complement is the best-measured arm of the humoral response, with demonstrable consumption of C3, C4 and C1 esterase inhibitor activity.

Abnormal Maternal Proinflammatory Mediator Activation -> Pulmonary Mast Cell Degranulation UNKNOWN Typed UNKNOWN rather than DIRECT because the evidence for a mast cell arm is genuinely split - autopsy immunohistochemistry supports it, serum tryptase and urinary histamine measurements in living patients do not. See the controversy discussion.

Abnormal Maternal Proinflammatory Mediator Activation -> Pulmonary Vasoconstriction and Acute Pulmonary Hypertension DIRECT The anaphylactoid reaction produces pulmonary vasospasm directly, which is the entry point into the stereotyped haemodynamic sequence.

Abnormal Maternal Proinflammatory Mediator Activation -> Coagulation Activation and Fibrinogen Consumption DIRECT The same response activates platelets and the coagulation system, which is why the coagulopathy is a parallel arm of the syndrome rather than merely a consequence of shock.

Complement Activation and C1 Esterase Inhibitor Consumption -> Pulmonary Vasoconstriction and Acute Pulmonary Hypertension INDIRECT UNKNOWN INTERMEDIATES Complement activation is proposed to drive the immune cell activation that initiates the fatal cascade, but the intermediates between an anaphylatoxin and a constricted pulmonary artery are not identified in the cited evidence, so the edge is typed INDIRECT_UNKNOWN_INTERMEDIATES.

Complement Activation and C1 Esterase Inhibitor Consumption -> Hyperfibrinolysis Uncoupled from Coagulation Activation INDIRECT UNKNOWN INTERMEDIATES Thrombin-activatable fibrinolysis inhibitor also inhibits complement C3a and C5a, so its depletion in amniotic fluid embolism is interpreted by the source as consumption in suppressing activated complement. If that reading is right, complement activation is a cause of the fibrinolytic defect rather than a parallel finding - which is the strongest available link between the immune and coagulation arms of this disease.

Pulmonary Mast Cell Degranulation -> Pulmonary Vasoconstriction and Acute Pulmonary Hypertension UNKNOWN Mast cell mediators are vasoactive and would plausibly contribute to pulmonary vasoconstriction, but no cited source demonstrates that step in this disease. Typed UNKNOWN deliberately: the alternative was to omit the edge and lose the claim, or type it DIRECT and assert a mechanism nobody has shown.

Show evidence (4 references)

PMID:24402585 SUPPORT Human Clinical

"The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition."

States the abnormal-maternal-response model as the current account of pathophysiology.

PMID:7726251 SUPPORT Human Clinical

"The striking similarities between clinical and hemodynamic findings in amniotic fluid embolism and both anaphylaxis and septic shock suggest a common pathophysiologic mechanism for all these conditions."

The registry argument that founded this model, and the basis for the "misnomer" claim this entry's description repeats.

PMID:33345954 SUPPORT Human Clinical

"This doubling of reported atopy among cases suggests that an anaphylactoid reaction may be the inciting event for the cascade of adverse events that characterize AFE."

The contemporary registry's own inference from the atopy excess. Note the hedge - "suggests", "may be" - which is why the atopy observation supports the hypothesis rather than establishing it.

+ 1 more reference

Physical obstruction of the maternal pulmonary microvasculature by fetal material

mechanical_embolic_obstruction ALTERNATIVE

Evidence balance 2 support

The original account, and the one the disease is named for: fetal squames, lanugo hairs, vernix and mucin entering maternal vessels and physically obstructing the pulmonary and other microcirculations. It is retained as ALTERNATIVE rather than DEPRECATED because the Japanese registry programme explicitly reports two etiologies and keeps physical obstruction as one of them, and because fetal material in the pulmonary vasculature is a real autopsy finding. What it has lost is its status as a diagnostic criterion: squamous cells in the pulmonary circulation are no longer accepted as pathognomonic, and continued reliance on them is named as a source of misdiagnosis.

Pathograph links

Entry of Amniotic Fluid and Fetal Antigens into the Maternal Circulation -> Mechanical Obstruction of the Maternal Pulmonary Microvasculature DIRECT Under the alternative model the same entry event acts physically, the fetal particulate matter obstructing maternal microvessels.

Mechanical Obstruction of the Maternal Pulmonary Microvasculature -> Pulmonary Vasoconstriction and Acute Pulmonary Hypertension DIRECT Under this model raised pulmonary vascular resistance is produced by physical occlusion of the bed rather than by vasospasm. The two hypotheses converge here on the same downstream node, which is why the haemodynamic sequence is the same under either account.

Show evidence (2 references)

PMID:24888909 SUPPORT Human Clinical

"Those data showed that there were two etiologies of AFE: the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"

The registry statement that keeps mechanical obstruction as a live etiology alongside the anaphylactoid one, and the reason this group is ALTERNATIVE rather than DEPRECATED.

PMID:33345954 SUPPORT Human Clinical

"Continued erroneous reliance on the detection of squamous cells in the pulmonary circulation as a pathognomonic criterion for AFE diagnosis regardless of clinical presentation also plays a role in erroneous diagnoses."

PARTIAL because it does not refute the mechanism, only its diagnostic use. This is the boundary the entry draws: fetal material in the maternal pulmonary circulation may occur without being what causes the syndrome.

Discussions and Knowledge Gaps

Does mast cell degranulation contribute causally to amniotic fluid embolism, or is the pulmonary mast cell finding a post-mortem epiphenomenon?

CONTROVERSY OPEN controversy_afe_mast_cell_arm

Attached to

pathophysiology#Pulmonary Mast Cell Degranulation

The evidence splits cleanly by method rather than by quality. Pulmonary immunohistochemistry in fatal cases finds mast cell numbers comparable to anaphylactic deaths and far above traumatic controls, with extracellular tryptase indicating degranulation, and does not find it in other fatal pregnancies. Serological measurement disagrees: serum tryptase has been normal in fatal cases, and a controlled series measuring both serum tryptase and urinary histamine returned negative. This entry curates both on one node with opposing `supports` values rather than picking a side, and types the outgoing edge UNKNOWN. The distinction matters practically: if the arm is causal, tryptase is a candidate biomarker in a disease that has none.

Proposed experiments

Prospectively banked serial tryptase and complement in registry-confirmed cases

exp_afe_serial_tryptase_registry

Measure serum tryptase, complement components and C1 esterase inhibitor on timed samples drawn during the acute event in prospectively enrolled cases meeting validated research criteria, with peripartum controls. The existing serological studies are retrospective, variably timed, and frequently post-mortem - which is a sufficient explanation for the discordance on its own, and is exactly the confound a prospective design removes.

Show evidence (1 reference)

PMID:25807263 SUPPORT Human Clinical

"However, other reports of AFE cases, in which serum tryptase was detected, gave discordant results to the anaphylactic hypothesis."

The review's own acknowledgement that this arm of the evidence is discordant.

Why does this entry conform to the thrombogenesis module at the coagulation cascade node but not at the thrombus formation node?

INTERPRETATION RESOLVED interp_afe_thrombogenesis_conformance_boundary

Attached to

pathophysiology#Coagulation Activation and Fibrinogen Consumption pathophysiology#Hyperfibrinolysis Uncoupled from Coagulation Activation

The coagulation node conforms straightforwardly: prothrombin fragment 1+2 is markedly raised, fibrinogen is consumed and D-dimer rises, which is thrombin-driven fibrin formation by any reading. The thrombus formation node is deliberately not claimed. In amniotic fluid embolism the fibrin that forms is lysed as fast as it is made - fibrinolysis is hyperactive and uncoupled from coagulation activation - and the clinical expression is uncontrollable haemorrhage requiring transfusion and hysterectomy, not an occlusive thrombus. Claiming the thrombus node would assert a pathological structure that this disease characteristically fails to form, and would license downstream inferences about occlusion and ischaemic tissue injury that the evidence does not support. Recorded as RESOLVED rather than OPEN because this is a curation decision with a stated rationale, not an unanswered question.

Show evidence (1 reference)

PMID:32157417 SUPPORT Human Clinical

"Disproportionately low levels of fibrinogen and factor five, and exorbitantly elevated D-dimers were present in all cases, whereas markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced."

The dissociation that justifies the boundary: the profile is lytic rather than purely consumptive, and platelets - required for the module's fibrin-platelet thrombus - are barely affected.

Can a biomarker distinguish amniotic fluid embolism from the obstetric conditions it is confused with, given that every candidate tested so far has failed?

KNOWLEDGE GAP OPEN gap_afe_no_diagnostic_test

Attached to

pathophysiology#Abnormal Maternal Proinflammatory Mediator Activation

This gap propagates into everything else in the entry. Without a test the case definition is a set of clinical criteria, competing criteria sets do not agree with each other, and the resulting cohorts differ enough that incidence and mortality estimates are not comparable across studies. Nearly half the charts submitted to the US registry as amniotic fluid embolism did not survive expert review. A 2024 reappraisal reported that none of its 29 cases met the Clark criteria while all met the authors' own - which is a statement about the criteria, not about the patients. Until this is closed, every epidemiological and mechanistic number in this entry inherits an unquantified case-definition error.

Proposed experiments

Prospective multi-analyte panel against expert-adjudicated case status

exp_afe_prospective_biomarker_panel

Evaluate a combined panel - complement components, C1 esterase inhibitor activity, tryptase, fibrinolytic markers - in prospectively collected peripartum-collapse cases adjudicated by expert chart review against published research criteria, with the comparator being the conditions amniotic fluid embolism is actually confused with (postpartum haemorrhage, sepsis, anaesthetic complication) rather than healthy controls. Single analytes have been tested this way and failed; whether a combination separates the groups has not been established.

Show evidence (2 references)

PMID:33345954 SUPPORT Human Clinical

"our data confirm the frequent misdiagnosis of AFE; almost one-half of patients whose diagnosis was believed to be sufficiently secure to prompt submission to the national registry did not, upon careful review of medical records, have confirmed AFE"

Quantifies the magnitude of the case-definition problem in the best-curated available series.

PMID:38082418 SUPPORT Human Clinical

"None of the cases met Clark's criteria while all met our criteria."

A direct demonstration that two published criteria sets can classify the same 29 patients in completely opposite ways.

Are there modifiable obstetric risk factors for amniotic fluid embolism, or are the reported associations artefacts of case ascertainment?

CONTROVERSY OPEN controversy_afe_risk_factors

Attached to

pathophysiology#Breach of the Maternal-Fetal Physiologic Barrier

Large administrative cohorts report reproducible associations - medical induction of labour roughly doubling the risk, and raised risk with maternal age, caesarean or instrumental delivery, polyhydramnios, cervical laceration or uterine rupture, placenta previa or abruption and eclampsia. Chart-reviewed registry work reaches the opposite practical conclusion: no risk factor justifies modifying obstetric practice, and the disease is unpredictable and unpreventable. The two are not straightforwardly reconcilable, and the proposed explanation is methodological - administrative datasets are known to include substantial numbers of women who did not have the disease, which is precisely the population in which induction, caesarean and haemorrhage-related codes would cluster. The registry series does independently observe excess placenta previa, atopy and in-vitro fertilisation, so this entry does not treat all associations as artefact; it declines to convert any of them into a mechanism node.

Show evidence (4 references)

PMID:17055946 SUPPORT Human Clinical

"Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism"

The strongest population-level association claim, from a three-million-delivery cohort.

PMID:17055946 SUPPORT Human Clinical

"Maternal age of 35 years or older, caesarean or instrumental vaginal delivery, polyhydramnios, cervical laceration or uterine rupture, placenta previa or abruption, eclampsia, and fetal distress were also associated with an increased risk."

The full set of associations reported by the same cohort.

PMID:24402585 REFUTE Human Clinical

"Data regarding the presence of risk factors for amniotic fluid embolism are inconsistent and contradictory; at present, no putative risk factor has been identified that would justify modification of standard obstetric practice to reduce the risk of this condition."

The counter-position, from the author of the original registry. Recorded as REFUTE against the risk-factor claim rather than being softened - the disagreement is the content of this discussion.

+ 1 more reference

Should the entity continue to be called amniotic fluid embolism when the dominant mechanistic account is not embolic?

INTERPRETATION OPEN interp_afe_misnomer

Attached to

pathophysiology#Mechanical Obstruction of the Maternal Pulmonary Microvasculature

The registry analysis that first characterised the syndrome concluded outright that the name is a misnomer, and proposed "anaphylactoid syndrome of pregnancy" instead - retained here as a synonym. The name has nonetheless persisted for three decades, and MONDO, ICD and every cited guideline use it. This is recorded because the name actively misleads: it names the alternative hypothesis, not the canonical one, and the historical reliance on pulmonary squamous cells as a pathognomonic finding - now identified as a source of misdiagnosis - is a direct consequence of taking the name literally.

Show evidence (1 reference)

PMID:7726251 SUPPORT Human Clinical

"Thus the term amniotic fluid embolism appears to be a misnomer."

The source of the misnomer claim.

⚙

Pathophysiology

Breach of the Maternal-Fetal Physiologic Barrier

The initiating event is a loss of separation between the amniotic compartment and the maternal circulation during parturition - through the endocervical veins, the placental implantation site, or a surgical or traumatic uterine breach. This is a normal-anatomy failure of an ordinary process rather than a lesion: small quantities of fetal material enter the maternal circulation in many uneventful labours, so the breach is necessary but not sufficient, and what follows depends on the host response.

parturition GO:0007567

Downstream

Entry of Amniotic Fluid and Fetal Antigens into the Maternal Circulation The breach is simply the route; what crosses it is the amniotic fluid and fetal cellular material that the maternal system then responds to.

Show evidence (1 reference)

PMID:24402585 SUPPORT Human Clinical

"breaches of the maternal-fetal physiologic barrier during parturition"

Names the barrier breach and its timing as the initiating condition.

Entry of Amniotic Fluid and Fetal Antigens into the Maternal Circulation

Amniotic fluid carrying fetal squamous cells, lanugo, vernix, mucin and soluble fetal antigens enters the maternal venous circulation and reaches the pulmonary vascular bed. This node is deliberately atomic and deliberately neutral between the two hypotheses in this entry: it is the last step both accounts share. Everything after it forks, into a maternal humoral response (canonical) or a physical obstruction (alternative).

Abnormal maternal humoral/anaphylactoid response to fetal antigen exposure Physical obstruction of the maternal pulmonary microvasculature by fetal material

Downstream

Abnormal Maternal Proinflammatory Mediator Activation Under the canonical model the fetal antigen load provokes a systemic humoral response rather than acting mechanically.

Mechanical Obstruction of the Maternal Pulmonary Microvasculature Under the alternative model the same entry event acts physically, the fetal particulate matter obstructing maternal microvessels.

Show evidence (1 reference)

PMID:33345954 SUPPORT Human Clinical

"may enhance the opportunity for large volumes of amniotic fluid to enter maternal circulation"

PARTIAL because the sentence is offered as one of two speculative explanations for the placenta previa excess, not as an established quantitative claim about entry volume.

Abnormal Maternal Proinflammatory Mediator Activation

The canonical hub of this entry. Exposure to fetal antigen provokes a systemic humoral response in the susceptible host, with proinflammatory mediator activation resembling the systemic inflammatory response syndrome and haemodynamics indistinguishable from anaphylaxis and septic shock. The node is scaled ORGANISM because the claim is about a whole-body mediator state rather than about any one cell or tissue; the complement and mast cell arms below are its identified molecular and cellular components.

Abnormal maternal humoral/anaphylactoid response to fetal antigen exposure

acute inflammatory response GO:0002526 ↑ INCREASED Temporal: ACUTE

Downstream

Complement Activation and C1 Esterase Inhibitor Consumption Complement is the best-measured arm of the humoral response, with demonstrable consumption of C3, C4 and C1 esterase inhibitor activity.

Pulmonary Mast Cell Degranulation Typed UNKNOWN rather than DIRECT because the evidence for a mast cell arm is genuinely split - autopsy immunohistochemistry supports it, serum tryptase and urinary histamine measurements in living patients do not. See the controversy discussion.

Pulmonary Vasoconstriction and Acute Pulmonary Hypertension The anaphylactoid reaction produces pulmonary vasospasm directly, which is the entry point into the stereotyped haemodynamic sequence.

Coagulation Activation and Fibrinogen Consumption The same response activates platelets and the coagulation system, which is why the coagulopathy is a parallel arm of the syndrome rather than merely a consequence of shock.

Show evidence (3 references)

PMID:24402585 SUPPORT Human Clinical

"This response and its subsequent injury appear to involve activation of proinflammatory mediators similar to that seen with the classic systemic inflammatory response syndrome."

The core statement that this node represents.

PMID:7726251 SUPPORT Human Clinical

"Clinical and hemodynamic manifestations were similar to those manifest in anaphylaxis and septic shock."

The registry observation that made a shared mediator-driven mechanism the leading account.

PMID:35840499 SUPPORT Human Clinical

"maternal inflammatory response and activation of the immune and complement systems appear to play leading roles"

Independent review attributing the leading mechanistic role to the maternal inflammatory and complement response. Note "appear to" - this is the field's consensus reading, not a demonstrated causal chain.

Complement Activation and C1 Esterase Inhibitor Consumption

Complement components are consumed in amniotic fluid embolism, and the principal regulator of the classical pathway is consumed with them. C3 and C4 fall markedly in the disseminated-intravascular-coagulation presentation, and C1 esterase inhibitor activity is roughly half that of control pregnant women and lower still in fatal cases - a dose-response relationship with outcome that is unusual in this disease, where almost nothing correlates with anything. C1 esterase inhibitor is not only a complement regulator: it also inhibits plasma kallikrein and factors XIIa and XIa, which is what ties this node mechanistically to the coagulofibrinolytic arm rather than leaving it a parallel curiosity.

Abnormal maternal humoral/anaphylactoid response to fetal antigen exposure

complement activation GO:0006956 ↑ INCREASED

serine-type endopeptidase inhibitor activity GO:0004867 ↓ DECREASED

Downstream

Pulmonary Vasoconstriction and Acute Pulmonary Hypertension Complement activation is proposed to drive the immune cell activation that initiates the fatal cascade, but the intermediates between an anaphylatoxin and a constricted pulmonary artery are not identified in the cited evidence, so the edge is typed INDIRECT_UNKNOWN_INTERMEDIATES.

Hyperfibrinolysis Uncoupled from Coagulation Activation Thrombin-activatable fibrinolysis inhibitor also inhibits complement C3a and C5a, so its depletion in amniotic fluid embolism is interpreted by the source as consumption in suppressing activated complement. If that reading is right, complement activation is a cause of the fibrinolytic defect rather than a parallel finding - which is the strongest available link between the immune and coagulation arms of this disease.

Show evidence (4 references)

PMID:24888909 SUPPORT Human Clinical

"a marked reduction of C3 and C4 was observed in DIC type AFE"

Documents complement component consumption, specifically in the coagulopathic presentation.

PMID:24561565 SUPPORT Human Clinical

"C1 esterase inhibitor activity levels were significantly lower in amniotic fluid embolism patients (30.0% ± 1.8%) than in control women (62.0% ± 2.0%) (p < 0.0001)."

Quantifies the C1 esterase inhibitor deficit against pregnant controls in 106 registry cases.

PMID:24561565 SUPPORT Human Clinical

"C1 esterase inhibitor activity levels in fatal amniotic fluid embolism cases (22.5% ± 3.4%) were significantly lower than those in nonfatal amniotic fluid embolism cases (32.0% ± 2.1%) (p < 0.05)."

The severity gradient - lower activity in fatal than non-fatal cases - which is what raises this above a bystander association.

+ 1 more reference

Pulmonary Mast Cell Degranulation

A contested node, retained because the disagreement is itself informative. Autopsy immunohistochemistry finds increased pulmonary mast cell numbers in fatal amniotic fluid embolism, at levels comparable to anaphylactic deaths and far above traumatic controls, with extracellular tryptase indicating degranulation. But serum tryptase in living or recently deceased patients is inconsistent - normal in some fatal cases, and negative in a controlled series that also measured urinary histamine. The honest reading is that mast cell degranulation occurs in the lung in fatal cases without being established as a driver of the syndrome, and it is certainly not a usable diagnostic marker.

Abnormal maternal humoral/anaphylactoid response to fetal antigen exposure

mast cell CL:0000097

mast cell degranulation GO:0043303 ↑ INCREASED

Downstream

Pulmonary Vasoconstriction and Acute Pulmonary Hypertension Mast cell mediators are vasoactive and would plausibly contribute to pulmonary vasoconstriction, but no cited source demonstrates that step in this disease. Typed UNKNOWN deliberately: the alternative was to omit the edge and lose the claim, or type it DIRECT and assert a mechanism nobody has shown.

Show evidence (3 references)

PMID:25807263 SUPPORT Human Clinical

"These studies, therefore, highlight that mast cell degranulation occurs in the lungs of AFE fatal cases, whereas it does not occur in other fatal pregnancies."

The positive histological evidence, with a pregnancy-matched comparison group.

PMID:25807263 REFUTE Human Clinical

"the results obtained were negative for serum tryptase and urinary histamine measurements in women with AFE"

The controlled negative series. Recorded as REFUTE and kept on the same node as the supporting evidence, because splitting them across nodes would hide the contradiction rather than curate it.

PMID:25807263 SUPPORT Human Clinical

"However, other reports of AFE cases, in which serum tryptase was detected, gave discordant results to the anaphylactic hypothesis."

The review's own summary that the serological arm of the anaphylactic hypothesis is discordant.

Mechanical Obstruction of the Maternal Pulmonary Microvasculature

The alternative arm. Fetal squamous cells, lanugo hairs, vernix and mucin lodged in the maternal pulmonary microcirculation, obstructing flow. The material is demonstrably there at autopsy; what is contested is whether its presence causes the syndrome or merely accompanies it, and its former status as a pathognomonic diagnostic criterion has been withdrawn.

Physical obstruction of the maternal pulmonary microvasculature by fetal material

blood vessel endothelial cell CL:0000071

Downstream

Pulmonary Vasoconstriction and Acute Pulmonary Hypertension Under this model raised pulmonary vascular resistance is produced by physical occlusion of the bed rather than by vasospasm. The two hypotheses converge here on the same downstream node, which is why the haemodynamic sequence is the same under either account.

Show evidence (2 references)

PMID:24888909 SUPPORT Human Clinical

"the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"

States the obstruction mechanism this node represents, as one of two etiologies recognised by the Japanese registry.

PMID:26703453 SUPPORT INDIRECT Human Clinical

"as a post mortem diagnosis (presence of fetal squames/debris in the pulmonary circulation)"

Confirms fetal material in the pulmonary circulation is a recognised post-mortem finding. INDIRECT because being a diagnostic criterion is not evidence that obstruction is the operative mechanism.

Pulmonary Vasoconstriction and Acute Pulmonary Hypertension

The convergence point of both hypotheses and the first step of the stereotyped haemodynamic sequence: pulmonary vascular resistance rises acutely. This is the node that makes the ordering of events clinically actionable, because everything downstream is right-heart failure before it is left-heart failure.

vasoconstriction GO:0042310 ↑ INCREASED Temporal: ACUTE

Downstream

Acute Right Ventricular Failure A pressure load imposed suddenly on a ventricle unadapted to it. The right ventricle fails before the left, and in that order.

Acute Hypoxaemic Respiratory Failure Loss of effective pulmonary perfusion produces acute hypoxaemia, which together with hypotension and coagulopathy forms the diagnostic triad.

Show evidence (1 reference)

PMID:33345954 SUPPORT Human Clinical

"Available evidence suggests that the hemodynamic response to AFE initially presents with increased pulmonary vascular resistance, and right ventricular failure, followed by left ventricular dysfunction."

The single sentence that establishes the whole ordered haemodynamic sequence curated in the next three nodes.

Acute Right Ventricular Failure

The right ventricle, acutely pressure-loaded, dilates and fails. This is the node with the most direct therapeutic consequence in the entry: it is identifiable at the bedside by echocardiography, and identifying it changes management, because a failing right ventricle is supported with inotropes, pulmonary vasodilators and vasopressors rather than with fluid.

Downstream

Left Ventricular Dysfunction and Cardiovascular Collapse Right ventricular failure is followed by left ventricular dysfunction; the registry evidence states the order rather than leaving it to inference.

Show evidence (1 reference)

PMID:31376394 SUPPORT Human Clinical

"we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle"

Establishes right ventricular failure as a discrete, detectable state central to early management.

Left Ventricular Dysfunction and Cardiovascular Collapse

Systemic circulatory failure - profound hypotension progressing in many cases to cardiac arrest. This is the presentation that brings the diagnosis to mind, and the reason resuscitation rather than diagnosis is the first action.

Downstream

Hypoxic-Ischaemic Maternal Organ Injury Global hypoperfusion during collapse and arrest is what produces the neurological injury seen in survivors.

Fetal Hypoxia Secondary to Maternal Circulatory Failure With the fetus still in utero, maternal circulatory failure is transmitted directly to the uteroplacental circulation. This is the two-organism step: the lesion is entirely maternal and the injury is fetal.

Show evidence (2 references)

PMID:33345954 SUPPORT Human Clinical

"The classic clinical signs of AFE, including peripartum respiratory distress, hypoxia, profound hypotension, cardiovascular collapse, and disseminated intravascular coagulopathy"

Names cardiovascular collapse and profound hypotension among the consistent clinical features.

PMID:32157417 SUPPORT Human Clinical

"It is characterized by cardiovascular compromise, loss of consciousness or other neurologic symptoms, and coagulopathy."

Independent statement of the cardiovascular-neurologic-coagulopathic triad.

Coagulation Activation and Fibrinogen Consumption

Systemic activation of coagulation with thrombin generation and consumption of fibrinogen. Prothrombin fragment 1+2 - a direct marker of thrombin generation - is markedly raised, Clauss fibrinogen falls to very low values and D-dimer rises. Disseminated intravascular coagulation is documented in 83-100% of reported cases regardless of delivery mode, which makes it a defining arm of the syndrome rather than a complication of some presentations. This node declares conformance to the thrombogenesis module's coagulation cascade node and to no other node in that module - see the discussion on why the thrombus-formation node is deliberately not claimed.

platelet CL:0000233

blood coagulation GO:0007596 ↑ INCREASED Temporal: ACUTE

Downstream

Haemostatic Failure and Obstetric Haemorrhage Consumption of fibrinogen and clotting factors leaves the uterus unable to achieve haemostasis after delivery.

Show evidence (3 references)

PMID:33345954 SUPPORT Human Clinical

"In all registries and research reports, 83–100% of patients demonstrated laboratory abnormalities or clinical findings consistent with DIC, regardless of mode of delivery."

Establishes the coagulopathy as near-universal and independent of delivery mode.

PMID:38168649 SUPPORT Human Clinical

"We found that AFE and sPA patients had low platelet counts as well as disturbed coagulation function due to the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"

The measured coagulation profile - fibrinogen consumption with raised D-dimer - underlying this node.

PMID:38168649 SUPPORT Human Clinical

"Both AFE and sPA were associated with activation of coagulation and massive fibrinolysis"

The thrombin-generation half of the finding, and the basis for the thrombogenesis module conformance declared on this node.

Hyperfibrinolysis Uncoupled from Coagulation Activation

The mechanistically distinctive finding of this entry, and the reason amniotic fluid embolism coagulopathy is not simply "severe DIC". In a direct comparison with severe placental abruption - a disease matched for coagulation activation, fibrinogen depletion and D-dimer rise - fibrinolytic activation in amniotic fluid embolism was hyperactive and did *not* correlate with coagulation activation, whereas in abruption the two were positively correlated. Tissue plasminogen activator was higher and total thrombin-activatable fibrinolysis inhibitor lower than in either abruption or controls. Bedside serial testing shows the same picture from the other side: fibrinogen and factor V disproportionately low and D-dimers exorbitant while platelets and antithrombin - the markers of pure consumption - are only slightly reduced. The therapeutic consequence is direct: it is the rationale for early antifibrinolytic therapy alongside factor replacement, rather than factor replacement alone.

fibrinolysis GO:0042730 ↑ INCREASED Temporal: ACUTE

Downstream

Haemostatic Failure and Obstetric Haemorrhage Premature lysis of formed clot compounds factor consumption, so bleeding continues even where coagulation factors are replaced.

Show evidence (4 references)

PMID:38168649 SUPPORT Human Clinical

"we found that fibrinolysis in AFE showed hyperactivation without correlating to the enhanced coagulation, compared to the significant positive correlation between activated coagulation and hyperfibrinolysis in sPA"

The uncoupling itself, established against a disease-matched comparator rather than against healthy controls - which is what makes it specific to amniotic fluid embolism rather than generic to obstetric DIC.

PMID:38168649 SUPPORT Human Clinical

"The contribution of a significant increase of tPA on producing plasmin in plasma, as well as decrease of TAFI and/or TAFIa may combine to promote fibrinolytic hyperactivity"

Names the two measured components - raised tissue plasminogen activator and depleted TAFI - proposed to produce the hyperfibrinolytic state.

PMID:32157417 SUPPORT Human Clinical

Independent bedside confirmation, and the sharpest statement of why this is not adequately described as consumptive coagulopathy.

+ 1 more reference

Haemostatic Failure and Obstetric Haemorrhage

Clinical bleeding, typically atonic postpartum haemorrhage compounded by an inability to form stable clot. This is the arm that drives transfusion, hysterectomy and much of the non-fatal morbidity, and it is the reason the guideline recommendation is to assess clotting status early rather than after bleeding is established.

Show evidence (2 references)

PMID:26987420 SUPPORT Human Clinical

"because coagulopathy may follow cardiovascular collapse with amniotic fluid embolism, we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"

Establishes clinical bleeding as an expected consequence requiring pre-emptive management.

PMID:26703453 SUPPORT Human Clinical

"18% (n = 6) had a hysterectomy and 85% (n = 28) received a transfusion of blood or blood products"

Quantifies the haemorrhagic burden at population level - most patients transfused, nearly a fifth hysterectomised.

Acute Hypoxaemic Respiratory Failure

Abrupt hypoxaemia with dyspnoea, cyanosis and in severe cases respiratory arrest, frequently progressing to acute respiratory distress syndrome in survivors of the initial event. Hypoxia is one of the three cardinal diagnostic features alongside hypotension and coagulopathy.

Downstream

Hypoxic-Ischaemic Maternal Organ Injury Failure of oxygenation compounds the perfusion failure in producing organ injury, particularly neurological.

Show evidence (2 references)

PMID:25807263 SUPPORT Human Clinical

"acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)"

Names the respiratory presentation and its component signs.

PMID:35840499 SUPPORT Human Clinical

"it is more often related to acute respiratory distress syndrome from obstetric complications"

PARTIAL: places amniotic fluid embolism among the obstetric causes of maternal ARDS without quantifying its contribution.

Hypoxic-Ischaemic Maternal Organ Injury

The end state in survivors: neurological injury from the arrest and hypoperfusion, ranging from seizures and coma at presentation to cerebral infarction and permanent deficit. Neurologically intact survival, not survival, is the meaningful outcome measure in this disease - the two figures differ substantially in every registry that reports both.

Show evidence (2 references)

PMID:7726251 SUPPORT Human Clinical

"Maternal mortality was 61%, with neurologically intact survival seen in 15% of women."

The original registry figures, and the clearest demonstration that survival and intact survival are different quantities.

PMID:21126320 SUPPORT Human Clinical

"survivors were at increased risk of cerebral infarction"

Population-level evidence of ischaemic brain injury as a survivor outcome.

Fetal Hypoxia Secondary to Maternal Circulatory Failure

Where the fetus is in utero at the time of the event, maternal circulatory collapse is transmitted to the uteroplacental circulation and produces acute fetal hypoxaemia and acidaemia. The lesion is wholly maternal and the injury wholly fetal, which is why the therapeutic response - immediate delivery - treats the fetus by separating it from the maternal circulation rather than by treating anything in the fetus.

Show evidence (2 references)

PMID:33345954 SUPPORT Human Clinical

"A total of 30 newborns (51%) born to women with typical AFE had Apgar scores < 7 at 1 minute and were acidemic (mean arterial pH was 6.95)."

Quantifies the fetal insult - half of newborns depressed and acidaemic, with a profoundly low mean arterial pH.

PMID:7726251 SUPPORT Human Clinical

"Of fetuses in utero at the time of the event, only 39% survived."

The historical fetal survival figure, and the reason this node is curated separately from the maternal outcome node.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Blood 2

Disseminated Intravascular Coagulation VERY_FREQUENT HP:0005521

Show evidence (1 reference)

PMID:33345954 SUPPORT Human Clinical

"In all registries and research reports, 83–100% of patients demonstrated laboratory abnormalities or clinical findings consistent with DIC, regardless of mode of delivery."

Directly quantifies the frequency band. This is the rare case where a frequency qualifier has its own quantitative support: 83-100% spans the VERY_FREQUENT band (80-99%) and above.

Thrombocytopenia HP:0001873

Show evidence (1 reference)

PMID:32157417 SUPPORT Human Clinical

"markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced"

Records the platelet change and, importantly, its mildness - which is the observation this phenotype exists to preserve.

Cardiovascular 3

Cardiovascular Collapse and Cardiac Arrest HP:0001695

Temporal: ACUTE

Show evidence (2 references)

PMID:26987420 SUPPORT Human Clinical

"we recommend consideration of amniotic fluid embolism in the differential diagnosis of sudden cardiorespiratory collapse in the laboring or recently delivered woman"

Establishes sudden cardiorespiratory collapse in the peripartum window as the presenting phenotype.

PMID:26703453 SUPPORT Human Clinical

"Thirteen (42%) women required cardiopulmonary resuscitation"

Quantifies how often the presentation reaches arrest in a population-based series.

Profound Hypotension HP:0002615

Temporal: ACUTE Severity: SEVERE

Show evidence (1 reference)

PMID:25807263 SUPPORT Human Clinical

"acute hypotension and/or cardiac arrest"

Names acute hypotension as a defining component of the clinical course.

Cerebral Infarction in Survivors Ischemic stroke HP:0002140

Show evidence (1 reference)

PMID:21126320 SUPPORT Human Clinical

"survivors were at increased risk of cerebral infarction"

The population-level survivor outcome this phenotype records.

Integument 1

Cyanosis HP:0000961

Temporal: ACUTE

Show evidence (1 reference)

PMID:25807263 SUPPORT Human Clinical

"with dyspnoea, cyanosis and/or respiratory arrest"

Names cyanosis among the acute respiratory signs.

Metabolism 1

Pulmonary Oedema Pulmonary edema HP:0100598

Show evidence (1 reference)

PMID:33345954 SUPPORT Human Clinical

"Both pulmonary edema and maternal neurologic injury were significantly more frequent among survivors of typical AFE"

Establishes pulmonary oedema as a measured, severity-tracking feature in the registry.

Nervous System 2

Seizures HP:0001250

Temporal: ACUTE

Show evidence (1 reference)

PMID:28188959 SUPPORT Human Clinical

"the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC)"

Names seizures among the defining acute features.

Coma HP:0001259

Temporal: ACUTE

Show evidence (1 reference)

PMID:25807263 SUPPORT Human Clinical

"coagulopathies (disseminated intravascular coagulation and/or severe hemorrhage), coma and seizures"

Names coma among the acute clinical features.

Respiratory 3

Acute Hypoxaemia Hypoxemia HP:0012418

Temporal: ACUTE

Show evidence (1 reference)

PMID:28188959 SUPPORT Human Clinical

"characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy"

Lists abrupt hypoxia first among the defining features.

Dyspnoea Dyspnea HP:0002094

Temporal: ACUTE

Show evidence (1 reference)

PMID:25807263 SUPPORT Human Clinical

"acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)"

Names dyspnoea as a component of the acute respiratory presentation.

Respiratory Failure Requiring Ventilatory Support HP:0002878

Temporal: ACUTE

Show evidence (1 reference)

PMID:26703453 SUPPORT Human Clinical

"Twenty (61%) were admitted to an Intensive Care Unit (ICU)"

Proxy evidence for the intensity of respiratory and circulatory support required. Recorded here because the ICU admission rate is the measured quantity; the entry does not claim a specific ventilation rate.

Other 2

Hypofibrinogenaemia Hypofibrinogenemia HP:0011900

Show evidence (1 reference)

PMID:38168649 SUPPORT Human Clinical

"the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"

Documents the fibrinogen depletion this phenotype records.

Postpartum Haemorrhage Post-partum hemorrhage HP:0011891

Severity: SEVERE

Show evidence (1 reference)

PMID:24888909 SUPPORT Human Clinical

"the presence of disseminated intravascular coagulation (DIC) and atonic bleeding"

Pairs atonic bleeding with the coagulopathy as the haemorrhagic presentation.

💊

Medical Actions

Immediate High-Quality Cardiopulmonary Resuscitation

Action: resuscitation Ontology label: Resuscitation NCIT:C50822

Because amniotic fluid embolism usually presents with cardiac arrest, standard basic and advanced cardiac life support is the first action - before, not after, any attempt at diagnosis.

Mechanism Target:

MODULATES Left Ventricular Dysfunction and Cardiovascular Collapse — Mechanical circulatory support sustains perfusion through the collapse; it does not act on any upstream step, which is why the effect is MODULATES rather than INHIBITS.

Show evidence (1 reference)

PMID:26987420 SUPPORT Human Clinical

"we recommend the provision of immediate high-quality cardiopulmonary resuscitation with standard basic cardiac life support and advanced cardiac life support protocols in patients who develop cardiac arrest associated with amniotic fluid embolism"

The graded guideline recommendation for this intervention against this node.

Show evidence (1 reference)

PMID:24402585 SUPPORT Human Clinical

"Maternal treatment is primarily supportive"

Establishes that the maternal treatment strategy as a whole is supportive rather than mechanism-directed.

Vasopressor and Inotropic Support Directed at the Failing Right Ventricle

Action: Pharmacotherapy NCIT:C15986

Agent: noradrenaline CHEBI:33569 milrinone CHEBI:50693

Blood-pressure support with vasopressors, and inotropes plus pulmonary vasodilators where echocardiography shows right ventricular failure. Volume loading is explicitly deprecated in severe right ventricular compromise, which is the practical payoff of curating the haemodynamic sequence in the right order.

Mechanism Target:

MODULATES Acute Right Ventricular Failure — Inotropic support acts on the failing right ventricle specifically, which is the node echocardiography identifies.

Show evidence (1 reference)

PMID:31376394 SUPPORT Human Clinical

"If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators."

Directs inotropes and pulmonary vasodilators specifically at right ventricular failure.

Show evidence (2 references)

PMID:31376394 SUPPORT Human Clinical

"Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise."

The negative half of the recommendation - vasopressors rather than fluid - which is what makes identifying the right ventricle worth doing.

PMID:26987420 SUPPORT Human Clinical

"the use of vasopressors and inotropic agents in the initial management of amniotic fluid embolism. Excessive fluid administration should be avoided"

Independent guideline statement of the same recommendation and the same caution against fluid.

Pulmonary Vasodilator Therapy

Action: Pharmacotherapy NCIT:C15986

Agent: inhaled nitric oxide CHEBI:16480

Inhaled or systemic pulmonary vasodilators to unload the right ventricle by reducing pulmonary vascular resistance. This is the one intervention in the entry that acts on a node upstream of the collapse rather than supporting the patient through it.

Mechanism Target:

INHIBITS Pulmonary Vasoconstriction and Acute Pulmonary Hypertension — Pulmonary vasodilation opposes the vasoconstriction that initiates the haemodynamic sequence.

Show evidence (1 reference)

PMID:31376394 SUPPORT Human Clinical

"treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators"

Names pulmonary vasodilators as an intervention in this setting. Note the source states the recommendation, not a measured reduction in pulmonary vascular resistance in this disease.

Haemostatic Resuscitation with Massive Transfusion Protocol

Action: blood transfusion Ontology label: Blood Transfusion NCIT:C15192

Balanced 1:1:1 replacement of packed red cells, fresh frozen plasma and platelets, with cryoprecipitate as needed to hold fibrinogen above roughly 150-200 mg/dL. Guidelines direct that clotting status be assessed early rather than after bleeding is established.

Mechanism Target:

RESTORES Haemostatic Failure and Obstetric Haemorrhage — Replacement of consumed factors and platelets restores the capacity to form clot; it does not address why they were consumed.

Show evidence (1 reference)

PMID:31376394 SUPPORT Human Clinical

"Amniotic fluid embolism-related coagulopathy should be managed with hemostatic resuscitation with the use of a 1:1:1 ratio of packed red cells, fresh frozen plasma, and platelets (with cryoprecipitate as needed to maintain a serum fibrinogen of >150-200 mg/dL)."

The specific replacement strategy and the fibrinogen target it is titrated to.

Show evidence (1 reference)

PMID:26987420 SUPPORT Human Clinical

"we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"

The graded guideline recommendation for early haemostatic assessment and massive transfusion.

Tranexamic Acid

Action: Pharmacotherapy NCIT:C15986

Agent: tranexamic acid CHEBI:48669

Antifibrinolytic therapy, proposed early in the treatment algorithm on the basis that the coagulopathy is hyperfibrinolytic and not purely consumptive. This is the one pharmacological intervention in the entry whose rationale follows from a specific mechanistic finding rather than from generic resuscitation practice - but the supporting evidence is a three-case observational series proposing an algorithm, not a trial, and it should be read that way.

Mechanism Target:

INHIBITS Hyperfibrinolysis Uncoupled from Coagulation Activation — Tranexamic acid inhibits fibrinolysis, which is the node the authors invoke to justify placing it early in the algorithm.

Show evidence (1 reference)

PMID:32157417 SUPPORT Human Clinical

"Our results support hyperfibrinolysis as contributing factor of AFE-associated coagulopathy. We, therefore, propose a treatment algorithm which includes early use of tranexamic acid"

PARTIAL deliberately. The authors propose the algorithm from their mechanistic finding; no outcome trial of tranexamic acid in amniotic fluid embolism is cited, so this edge records a rationale, not a demonstrated benefit.

Immediate Delivery Following Maternal Cardiac Arrest

Action: cesarean section Ontology label: Cesarean Section NCIT:C46088

Delivery of a fetus at 23 weeks or beyond immediately after maternal cardiac arrest. It is directed at the fetus - separating it from a failed maternal circulation - and is the only intervention in this entry that treats the second organism.

Mechanism Target:

BYPASSES Fetal Hypoxia Secondary to Maternal Circulatory Failure — Delivery does not correct the maternal lesion; it removes the fetus from dependence on it. BYPASSES rather than INHIBITS for exactly that reason.

Show evidence (1 reference)

PMID:24402585 SUPPORT Human Clinical

"prompt delivery of the mother who has sustained cardiopulmonary arrest is critical for improved newborn outcome"

States the indication and, specifically, that the benefit is to the newborn.

Show evidence (1 reference)

PMID:26987420 SUPPORT Human Clinical

"following cardiac arrest with amniotic fluid embolism, we recommend immediate delivery in the presence of a fetus ≥23 weeks of gestation"

The graded guideline recommendation, including the gestational-age threshold.

Venoarterial Extracorporeal Membrane Oxygenation

Action: extracorporeal membrane oxygenation Ontology label: Extracorporeal Membrane Oxygenation NCIT:C171507

Rescue mechanical circulatory support where cardiopulmonary resuscitation is prolonged, or ventricular dysfunction after arrest is refractory to medical management.

Mechanism Target:

BYPASSES Left Ventricular Dysfunction and Cardiovascular Collapse — Extracorporeal support substitutes for the failed cardiopulmonary unit rather than acting on it.

Show evidence (1 reference)

PMID:31376394 SUPPORT Human Clinical

"In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given."

States the indication and the refractory-failure context.

Oxygenation and Mechanical Ventilation

Action: mechanical ventilation Ontology label: Mechanical Ventilation NCIT:C70909

Airway control, oxygenation and ventilation as part of initial supportive management.

Mechanism Target:

MODULATES Acute Hypoxaemic Respiratory Failure — Ventilatory support corrects the gas-exchange failure without addressing its cause.

Show evidence (1 reference)

PMID:26987420 SUPPORT Human Clinical

"we recommend the provision of adequate oxygenation and ventilation"

The guideline recommendation for ventilatory support in initial management.

C1 Esterase Inhibitor Replacement (investigational)

Action: Pharmacotherapy NCIT:C15986

Not an established therapy. It is included because it is the only mechanism-directed candidate in this disease that follows from a measured deficit with a severity gradient - C1 esterase inhibitor activity is roughly half of control in affected women and lower again in fatal cases - and because the registry group that made that measurement proposed it as a treatment candidate on that basis. No trial evidence is cited.

Mechanism Target:

RESTORES Complement Activation and C1 Esterase Inhibitor Consumption — Replacement of the consumed inhibitor would restore regulation of the classical complement pathway and of the contact system.

Show evidence (1 reference)

PMID:24888909 SUPPORT Human Clinical

"C1 esterase inhibitor activity in AFE cases was significantly lower than those of normal pregnant women. C1 esterase inhibitor may be a promising candidate of treatment of AFE."

PARTIAL, and deliberately not upgraded: "may be a promising candidate" is a proposal from an observed deficit, not evidence of therapeutic effect.

🔬

Diagnosis

Clinical Diagnosis of Exclusion

Amniotic fluid embolism has no confirmatory test. Guidelines explicitly recommend against using any specific laboratory test to confirm or refute it, and every candidate biomarker studied - zinc coproporphyrin, sialyl Tn antigen, serum tryptase, complement C3 and C4 - has failed to prove reliable for prediction or diagnosis. The diagnosis is made clinically, from sudden cardiorespiratory collapse with coagulopathy in the peripartum window, once alternatives are excluded.

Show evidence (2 references)

PMID:26987420 SUPPORT Human Clinical

"we do not recommend the use of any specific diagnostic laboratory test to either confirm or refute the diagnosis of amniotic fluid embolism; at the present time, amniotic fluid embolism remains a clinical diagnosis"

The guideline statement that there is no confirmatory test.

PMID:33345954 SUPPORT Human Clinical

"have been studied and reported, but, to date, none appear reliable in predicting or diagnosing AFE"

Records that the candidate biomarker programme has not produced a usable test.

Echocardiographic Identification of Right Ventricular Failure

Not diagnostic of the syndrome, but the key management-directing investigation: transthoracic or transoesophageal echocardiography identifies the failing right ventricle, which determines whether inotropes, pulmonary vasodilators and vasopressors or volume are given.

Show evidence (1 reference)

PMID:31376394 SUPPORT Human Clinical

"we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle"

States the investigation, its timing, and what it identifies.

📊

Prevalence

Australia and New Zealand

Birth Prevalence 5.4 per 100,000 (3.5–7.2) 1–9 per 100,000

Reported by the source as an incidence of 5.4 cases per 100,000 women giving birth, from prospective surveillance covering an estimated 96% of Australian and 100% of New Zealand hospital births. Recorded as BIRTH_PREVALENCE because the denominator is births rather than person-time; it is not a congenital prevalence.

Show evidence (1 reference)

PMID:26703453 SUPPORT Human Clinical

"with an estimated incidence of 5.4 cases per 100,000 women giving birth (95% CI 3.5 to 7.2 per 100,000)"

The point estimate and confidence interval recorded in this record.

United States

Birth Prevalence 4.9 per 100,000 1–9 per 100,000

Twenty-year Nationwide Inpatient Sample series. Administrative-database derived, so per PMID:24402585 it is expected to overestimate incidence relative to chart-reviewed series.

Show evidence (1 reference)

PMID:38219609 SUPPORT Human Clinical

"Over the study period, AFE incidence rate remained stable (mean 4.9 cases/100,000 deliveries) and the case-fatality rate declined"

Gives the twenty-year mean incidence and the direction of the case-fatality trend.

Australia (linked population data)

Birth Prevalence 3.3 per 100,000 (1.9–4.7) 1–9 per 100,000

Whole-population linked birth, hospital and death data with additional case-definition criteria imposed.

Show evidence (1 reference)

PMID:21126320 SUPPORT Human Clinical

"The AFE incidence was 3.3 per 100,000 (95% CI, 1.9-4.7), maternal fatality rate 35% (95% CI, 15-59) and perinatal mortality rate 32% (95% CI, 12-56)."

Reports incidence together with maternal and perinatal fatality rates in the same cohort.

Canada (singleton deliveries)

Birth Prevalence 6.0 per 100,000 1–9 per 100,000

From a three-million-delivery cohort. The same study reports 14.8 per 100,000 for multiple-birth deliveries, so the denominator matters.

Show evidence (1 reference)

PMID:17055946 SUPPORT Human Clinical

"Total rate of amniotic-fluid embolism was 14.8 per 100,000 multiple-birth deliveries and 6.0 per 100,000 singleton deliveries"

Gives both singleton and multiple-birth rates from one national cohort.

⚖️

Clinical Burden

High

Amniotic fluid embolism is rare - roughly 3 to 6 cases per 100,000 deliveries across contemporary population studies - but it is a leading direct cause of maternal death in high-income countries, it is unpredictable and unpreventable, and survivors carry substantial morbidity including hysterectomy, cerebral infarction and post-traumatic stress. The burden is compounded by the absence of any disease-modifying treatment and by the absence of a diagnostic test.

Show evidence (3 references)

PMID:26703453 SUPPORT Human Clinical

"Amniotic fluid embolism (AFE) is a major cause of direct maternal mortality in Australia and New Zealand."

States the population-level burden as a leading direct cause of maternal death.

PMID:33345954 SUPPORT Human Clinical

"AFE remains both unpredictable and unpreventable."

The registry authors' own summary of why the burden cannot presently be reduced by changing obstetric practice.

PMID:28188959 SUPPORT Human Clinical

"A major concern is that there are no effective evidence-based therapies for AFE, because its pathophysiology is still not well understood."

States the absence of disease-modifying therapy that amplifies the burden.

🔀

Differential Diagnoses

Conditions with similar clinical presentations that must be differentiated from Amniotic Fluid Embolism:

Hypovolaemic shock from postpartum haemorrhage

Overlapping Features The single most common alternative diagnosis in cases submitted to the US registry as amniotic fluid embolism - 21 of the 27 charts with a definitive alternative diagnosis. Distinguishing them matters mechanistically, because in haemorrhagic shock the coagulopathy follows the blood loss whereas here it accompanies the collapse.

Show evidence (1 reference)

PMID:33345954 SUPPORT Human Clinical

"Of the 27 women misclassified as an amniotic fluid embolism with an alternative diagnosis, the most common actual diagnosis was hypovolemic shock secondary to postpartum hemorrhage."

Quantifies this as the leading misdiagnosis in a chart-reviewed registry.

Anaesthetic complication

Show evidence (1 reference)

PMID:33345954 SUPPORT Human Clinical

"followed by anesthetic complications (n = 4, 14.8%) and sepsis-related cardiovascular collapse (n = 2, 7.4%)"

Names anaesthetic complication and sepsis as the second and third alternative diagnoses in misclassified cases.

Severe placental abruption with disseminated intravascular coagulation

Overlapping Features Shares fibrinogen depletion, D-dimer elevation and thrombocytopenia. The discriminating feature in the one direct comparison is the *coupling* between coagulation and fibrinolysis, not the magnitude of either.

Show evidence (1 reference)

PMID:38168649 SUPPORT Human Clinical

"Both AFE and sPA were associated with activation of coagulation and massive fibrinolysis without significant difference in each plasma maker between the groups."

States that the individual coagulation markers do not separate the two diseases, which is why the discriminator has to be the correlation structure rather than any single value.

{ }

Source YAML

click to show

name: Amniotic Fluid Embolism
creation_date: "2026-08-17T09:00:00Z"
category: Complex
synonyms:
- AFE
- Anaphylactoid syndrome of pregnancy
description: >
  Amniotic fluid embolism is a sudden, catastrophic peripartum syndrome of
  cardiovascular collapse, hypoxaemia and coagulopathy that begins when the
  physiological barrier separating the fetal and maternal compartments is
  breached during labour, delivery or the immediate postpartum period. It is
  named for a mechanism it largely does not have. The historical account was
  mechanical - fetal squames, lanugo and vernix physically obstructing the
  maternal pulmonary microvasculature - but the national registry analysis that
  first characterised the syndrome systematically found its clinical and
  haemodynamic picture indistinguishable from anaphylaxis and septic shock, and
  concluded that the name is a misnomer. The dominant modern account is an
  abnormal maternal humoral response to fetal tissue exposure, with
  proinflammatory mediator activation resembling the systemic inflammatory
  response syndrome.

  Whatever initiates it, the haemodynamic sequence is stereotyped and ordered:
  pulmonary vasoconstriction raises pulmonary vascular resistance, the right
  ventricle fails acutely, and left ventricular dysfunction and systemic
  collapse follow. That ordering is a management decision rather than an
  academic one, because a failing right ventricle is treated with inotropes,
  pulmonary vasodilators and vasopressors rather than with volume.

  The coagulopathy is the part of this entry that is mechanistically
  distinctive rather than merely severe. Coagulation is activated and fibrinogen
  consumed, as in any disseminated intravascular coagulation - but in a direct
  comparison against severe placental abruption, fibrinolytic activation in
  amniotic fluid embolism was hyperactive and uncoupled from coagulation
  activation, with raised tissue plasminogen activator and depleted
  thrombin-activatable fibrinolysis inhibitor. Bedside series show the same
  signature from the other direction: fibrinogen and factor V disproportionately
  low and D-dimers exorbitant while platelets and antithrombin are only slightly
  reduced. The clinical expression is therefore haemorrhage, not occlusive
  thrombosis, which is why this entry claims module conformance for coagulation
  activation but deliberately not for thrombus formation.

  Two facts constrain everything above. There is no diagnostic test - amniotic
  fluid embolism remains a clinical diagnosis and no candidate biomarker has
  proved reliable - so the case definition itself is a moving quantity, and
  registries using expert chart review report systematically different incidence
  and mortality from administrative-database studies. And there is no
  disease-modifying therapy: every established intervention is supportive
  resuscitation, haemostatic replacement and prompt delivery.
disease_term:
  preferred_term: amniotic fluid embolism
  term:
    id: MONDO:0850046
    label: amniotic fluid embolism
parents:
- Pregnancy disorder
- Obstetric emergency
- Peripartum cardiovascular collapse

clinical_burden:
  burden_level: HIGH
  rationale: >
    Amniotic fluid embolism is rare - roughly 3 to 6 cases per 100,000 deliveries
    across contemporary population studies - but it is a leading direct cause of
    maternal death in high-income countries, it is unpredictable and
    unpreventable, and survivors carry substantial morbidity including
    hysterectomy, cerebral infarction and post-traumatic stress. The burden is
    compounded by the absence of any disease-modifying treatment and by the
    absence of a diagnostic test.
  evidence:
  - reference: PMID:26703453
    reference_title: "Amniotic fluid embolism: an Australian-New Zealand population-based study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Amniotic fluid embolism (AFE) is a major cause of direct maternal mortality in Australia and New Zealand."
    explanation: States the population-level burden as a leading direct cause of maternal death.
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "AFE remains both unpredictable and unpreventable."
    explanation: >
      The registry authors' own summary of why the burden cannot presently be
      reduced by changing obstetric practice.
  - reference: PMID:28188959
    reference_title: "Amniotic fluid embolism: Pathophysiology from the perspective of pathology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A major concern is that there are no effective evidence-based therapies for AFE, because its pathophysiology is still not well understood."
    explanation: States the absence of disease-modifying therapy that amplifies the burden.

prevalence:
- population: Australia and New Zealand
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 5.4
  rate_low: 3.5
  rate_high: 7.2
  notes: >
    Reported by the source as an incidence of 5.4 cases per 100,000 women giving
    birth, from prospective surveillance covering an estimated 96% of Australian
    and 100% of New Zealand hospital births. Recorded as BIRTH_PREVALENCE because
    the denominator is births rather than person-time; it is not a congenital
    prevalence.
  evidence:
  - reference: PMID:26703453
    reference_title: "Amniotic fluid embolism: an Australian-New Zealand population-based study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with an estimated incidence of 5.4 cases per 100,000 women giving birth (95% CI 3.5 to 7.2 per 100,000)"
    explanation: The point estimate and confidence interval recorded in this record.
- population: United States
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 4.9
  notes: >
    Twenty-year Nationwide Inpatient Sample series. Administrative-database
    derived, so per PMID:24402585 it is expected to overestimate incidence
    relative to chart-reviewed series.
  evidence:
  - reference: PMID:38219609
    reference_title: "Amniotic fluid embolism: 20-year incidence and case-fatality trends in the United States."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the study period, AFE incidence rate remained stable (mean 4.9 cases/100,000 deliveries) and the case-fatality rate declined"
    explanation: Gives the twenty-year mean incidence and the direction of the case-fatality trend.
- population: Australia (linked population data)
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 3.3
  rate_low: 1.9
  rate_high: 4.7
  notes: Whole-population linked birth, hospital and death data with additional case-definition criteria imposed.
  evidence:
  - reference: PMID:21126320
    reference_title: Amniotic fluid embolism in an Australian population-based cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The AFE incidence was 3.3 per 100,000 (95% CI, 1.9-4.7), maternal fatality rate 35% (95% CI, 15-59) and perinatal mortality rate 32% (95% CI, 12-56)."
    explanation: Reports incidence together with maternal and perinatal fatality rates in the same cohort.
- population: Canada (singleton deliveries)
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 6.0
  notes: >
    From a three-million-delivery cohort. The same study reports 14.8 per
    100,000 for multiple-birth deliveries, so the denominator matters.
  evidence:
  - reference: PMID:17055946
    reference_title: "Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Total rate of amniotic-fluid embolism was 14.8 per 100,000 multiple-birth deliveries and 6.0 per 100,000 singleton deliveries"
    explanation: Gives both singleton and multiple-birth rates from one national cohort.

mechanistic_hypotheses:
- hypothesis_group_id: anaphylactoid_immune_response
  hypothesis_label: Abnormal maternal humoral/anaphylactoid response to fetal antigen exposure
  status: CANONICAL
  description: >
    Under this model the injury is caused not by the physical presence of fetal
    material but by the maternal reaction to it. Fetal antigens entering the
    maternal circulation trigger proinflammatory mediator release resembling the
    systemic inflammatory response syndrome, with complement activation and
    kallikrein-kinin and coagulofibrinolytic involvement, in a susceptible host.
    The supporting arguments are the haemodynamic identity with anaphylaxis and
    septic shock, the excess of atopy among cases, and the measurable consumption
    of complement components and C1 esterase inhibitor. The model is explicitly
    non-IgE-mediated, which is why "anaphylactoid" rather than "anaphylactic" is
    the term used.
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition."
    explanation: States the abnormal-maternal-response model as the current account of pathophysiology.
  - reference: PMID:7726251
    reference_title: "Amniotic fluid embolism: analysis of the national registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The striking similarities between clinical and hemodynamic findings in amniotic fluid embolism and both anaphylaxis and septic shock suggest a common pathophysiologic mechanism for all these conditions."
    explanation: >
      The registry argument that founded this model, and the basis for the
      "misnomer" claim this entry's description repeats.
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This doubling of reported atopy among cases suggests that an anaphylactoid reaction may be the inciting event for the cascade of adverse events that characterize AFE."
    explanation: >
      The contemporary registry's own inference from the atopy excess. Note the
      hedge - "suggests", "may be" - which is why the atopy observation supports
      the hypothesis rather than establishing it.
  - reference: PMID:24865116
    reference_title: "Incidence, diagnosis and pathophysiology of amniotic fluid embolism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms."
    explanation: Names the immunological and complement mechanisms grouped under this hypothesis.
- hypothesis_group_id: mechanical_embolic_obstruction
  hypothesis_label: Physical obstruction of the maternal pulmonary microvasculature by fetal material
  status: ALTERNATIVE
  description: >
    The original account, and the one the disease is named for: fetal squames,
    lanugo hairs, vernix and mucin entering maternal vessels and physically
    obstructing the pulmonary and other microcirculations. It is retained as
    ALTERNATIVE rather than DEPRECATED because the Japanese registry programme
    explicitly reports two etiologies and keeps physical obstruction as one of
    them, and because fetal material in the pulmonary vasculature is a real
    autopsy finding. What it has lost is its status as a diagnostic criterion:
    squamous cells in the pulmonary circulation are no longer accepted as
    pathognomonic, and continued reliance on them is named as a source of
    misdiagnosis.
  evidence:
  - reference: PMID:24888909
    reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Those data showed that there were two etiologies of AFE: the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"
    explanation: >
      The registry statement that keeps mechanical obstruction as a live etiology
      alongside the anaphylactoid one, and the reason this group is ALTERNATIVE
      rather than DEPRECATED.
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Continued erroneous reliance on the detection of squamous cells in the pulmonary circulation as a pathognomonic criterion for AFE diagnosis regardless of clinical presentation also plays a role in erroneous diagnoses."
    explanation: >
      PARTIAL because it does not refute the mechanism, only its diagnostic use.
      This is the boundary the entry draws: fetal material in the maternal
      pulmonary circulation may occur without being what causes the syndrome.

pathophysiology:
- name: Breach of the Maternal-Fetal Physiologic Barrier
  biological_scale: TISSUE
  role: TRIGGER
  description: >
    The initiating event is a loss of separation between the amniotic compartment
    and the maternal circulation during parturition - through the endocervical
    veins, the placental implantation site, or a surgical or traumatic uterine
    breach. This is a normal-anatomy failure of an ordinary process rather than a
    lesion: small quantities of fetal material enter the maternal circulation in
    many uneventful labours, so the breach is necessary but not sufficient, and
    what follows depends on the host response.
  biological_processes:
  - preferred_term: parturition
    term:
      id: GO:0007567
      label: parturition
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "breaches of the maternal-fetal physiologic barrier during parturition"
    explanation: Names the barrier breach and its timing as the initiating condition.
  downstream:
  - target: Entry of Amniotic Fluid and Fetal Antigens into the Maternal Circulation
    causal_link_type: DIRECT
    description: >
      The breach is simply the route; what crosses it is the amniotic fluid and
      fetal cellular material that the maternal system then responds to.
    evidence:
    - reference: PMID:28188959
      reference_title: "Amniotic fluid embolism: Pathophysiology from the perspective of pathology."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "caused by the inflow of amniotic components into the maternal circulation"
      explanation: States the inflow of amniotic components as the proximate cause of the syndrome.

- name: Entry of Amniotic Fluid and Fetal Antigens into the Maternal Circulation
  biological_scale: ORGANISM
  description: >
    Amniotic fluid carrying fetal squamous cells, lanugo, vernix, mucin and
    soluble fetal antigens enters the maternal venous circulation and reaches the
    pulmonary vascular bed. This node is deliberately atomic and deliberately
    neutral between the two hypotheses in this entry: it is the last step both
    accounts share. Everything after it forks, into a maternal humoral response
    (canonical) or a physical obstruction (alternative).
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "may enhance the opportunity for large volumes of amniotic fluid to enter maternal circulation"
    explanation: >
      PARTIAL because the sentence is offered as one of two speculative
      explanations for the placenta previa excess, not as an established
      quantitative claim about entry volume.
  downstream:
  - target: Abnormal Maternal Proinflammatory Mediator Activation
    causal_link_type: DIRECT
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      Under the canonical model the fetal antigen load provokes a systemic
      humoral response rather than acting mechanically.
    evidence:
    - reference: PMID:24402585
      reference_title: Amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "This response and its subsequent injury appear to involve activation of proinflammatory mediators similar to that seen with the classic systemic inflammatory response syndrome."
      explanation: Links the maternal response to fetal tissue exposure to proinflammatory mediator activation.
  - target: Mechanical Obstruction of the Maternal Pulmonary Microvasculature
    causal_link_type: DIRECT
    hypothesis_groups:
    - mechanical_embolic_obstruction
    description: >
      Under the alternative model the same entry event acts physically, the fetal
      particulate matter obstructing maternal microvessels.
    evidence:
    - reference: PMID:24888909
      reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"
      explanation: States the physical-obstruction step this edge represents.

- name: Abnormal Maternal Proinflammatory Mediator Activation
  biological_scale: ORGANISM
  description: >
    The canonical hub of this entry. Exposure to fetal antigen provokes a
    systemic humoral response in the susceptible host, with proinflammatory
    mediator activation resembling the systemic inflammatory response syndrome
    and haemodynamics indistinguishable from anaphylaxis and septic shock. The
    node is scaled ORGANISM because the claim is about a whole-body mediator
    state rather than about any one cell or tissue; the complement and mast cell
    arms below are its identified molecular and cellular components.
  biological_processes:
  - preferred_term: acute inflammatory response
    term:
      id: GO:0002526
      label: acute inflammatory response
    modifier: INCREASED
    temporality: ACUTE
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This response and its subsequent injury appear to involve activation of proinflammatory mediators similar to that seen with the classic systemic inflammatory response syndrome."
    explanation: The core statement that this node represents.
  - reference: PMID:7726251
    reference_title: "Amniotic fluid embolism: analysis of the national registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical and hemodynamic manifestations were similar to those manifest in anaphylaxis and septic shock."
    explanation: The registry observation that made a shared mediator-driven mechanism the leading account.
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "maternal inflammatory response and activation of the immune and complement systems appear to play leading roles"
    explanation: >
      Independent review attributing the leading mechanistic role to the maternal
      inflammatory and complement response. Note "appear to" - this is the
      field's consensus reading, not a demonstrated causal chain.
  downstream:
  - target: Complement Activation and C1 Esterase Inhibitor Consumption
    causal_link_type: DIRECT
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      Complement is the best-measured arm of the humoral response, with
      demonstrable consumption of C3, C4 and C1 esterase inhibitor activity.
    evidence:
    - reference: PMID:24561565
      reference_title: C1 esterase inhibitor activity in amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Amniotic fluid embolism exhibits activation of the complement system and the kallikrein-kinin and coagulofibrinolytic systems."
      explanation: States complement activation as a component of the response, alongside the kallikrein-kinin and coagulofibrinolytic systems.
  - target: Pulmonary Mast Cell Degranulation
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      Typed UNKNOWN rather than DIRECT because the evidence for a mast cell arm
      is genuinely split - autopsy immunohistochemistry supports it, serum
      tryptase and urinary histamine measurements in living patients do not. See
      the controversy discussion.
    evidence:
    - reference: PMID:25807263
      reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Anaphylactoid reactions refer to an identical clinical pattern seen in the classical anaphylaxis, non-IgE mediated and certain allergens, including drugs can trigger the mast cell cascade directly without involving IgE as the initial mediator"
      explanation: >
        Gives the mechanistic rationale for a non-IgE mast cell arm. PARTIAL
        because it establishes that such a route exists in general, not that it
        operates in this disease.
  - target: Pulmonary Vasoconstriction and Acute Pulmonary Hypertension
    causal_link_type: DIRECT
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      The anaphylactoid reaction produces pulmonary vasospasm directly, which is
      the entry point into the stereotyped haemodynamic sequence.
    evidence:
    - reference: PMID:24888909
      reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the liquids cause an anaphylactoid reaction that leads to pulmonary vasospasm and activation of platelets, white blood cells and/or complements"
      explanation: States pulmonary vasospasm as the direct consequence of the anaphylactoid reaction.
  - target: Coagulation Activation and Fibrinogen Consumption
    causal_link_type: DIRECT
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      The same response activates platelets and the coagulation system, which is
      why the coagulopathy is a parallel arm of the syndrome rather than merely
      a consequence of shock.
    evidence:
    - reference: PMID:24888909
      reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "an anaphylactoid reaction that leads to pulmonary vasospasm and activation of platelets, white blood cells and/or complements"
      explanation: Names platelet activation as part of the same reaction that produces the vasospasm.

- name: Complement Activation and C1 Esterase Inhibitor Consumption
  biological_scale: MOLECULAR
  description: >
    Complement components are consumed in amniotic fluid embolism, and the
    principal regulator of the classical pathway is consumed with them. C3 and C4
    fall markedly in the disseminated-intravascular-coagulation presentation, and
    C1 esterase inhibitor activity is roughly half that of control pregnant women
    and lower still in fatal cases - a dose-response relationship with outcome
    that is unusual in this disease, where almost nothing correlates with
    anything. C1 esterase inhibitor is not only a complement regulator: it also
    inhibits plasma kallikrein and factors XIIa and XIa, which is what ties this
    node mechanistically to the coagulofibrinolytic arm rather than leaving it a
    parallel curiosity.
  biological_processes:
  - preferred_term: complement activation
    term:
      id: GO:0006956
      label: complement activation
    modifier: INCREASED
  molecular_functions:
  - preferred_term: serine-type endopeptidase inhibitor activity
    term:
      id: GO:0004867
      label: serine-type endopeptidase inhibitor activity
    modifier: DECREASED
  evidence:
  - reference: PMID:24888909
    reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a marked reduction of C3 and C4 was observed in DIC type AFE"
    explanation: Documents complement component consumption, specifically in the coagulopathic presentation.
  - reference: PMID:24561565
    reference_title: C1 esterase inhibitor activity in amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "C1 esterase inhibitor activity levels were significantly lower in amniotic fluid embolism patients (30.0% ± 1.8%) than in control women (62.0% ± 2.0%) (p < 0.0001)."
    explanation: Quantifies the C1 esterase inhibitor deficit against pregnant controls in 106 registry cases.
  - reference: PMID:24561565
    reference_title: C1 esterase inhibitor activity in amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "C1 esterase inhibitor activity levels in fatal amniotic fluid embolism cases (22.5% ± 3.4%) were significantly lower than those in nonfatal amniotic fluid embolism cases (32.0% ± 2.1%) (p < 0.05)."
    explanation: >
      The severity gradient - lower activity in fatal than non-fatal cases -
      which is what raises this above a bystander association.
  - reference: PMID:24561565
    reference_title: C1 esterase inhibitor activity in amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "C1 esterase inhibitor is a major inhibitor of C1 esterase and can inhibit plasma kallikrein and also factors XIIa and XIa."
    explanation: Establishes the shared regulator linking the complement arm to contact-system and coagulation activation.
  downstream:
  - target: Pulmonary Vasoconstriction and Acute Pulmonary Hypertension
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      Complement activation is proposed to drive the immune cell activation that
      initiates the fatal cascade, but the intermediates between an anaphylatoxin
      and a constricted pulmonary artery are not identified in the cited
      evidence, so the edge is typed INDIRECT_UNKNOWN_INTERMEDIATES.
    evidence:
    - reference: PMID:24865116
      reference_title: "Incidence, diagnosis and pathophysiology of amniotic fluid embolism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Immune cell activation induced through complement activation may be associated with the mechanism that immediately initiates maternal death, only in susceptible individuals."
      explanation: >
        PARTIAL and INDIRECT together: the source says "may be associated with",
        and names no intermediate step.
  - target: Hyperfibrinolysis Uncoupled from Coagulation Activation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      Thrombin-activatable fibrinolysis inhibitor also inhibits complement C3a and
      C5a, so its depletion in amniotic fluid embolism is interpreted by the
      source as consumption in suppressing activated complement. If that reading
      is right, complement activation is a cause of the fibrinolytic defect
      rather than a parallel finding - which is the strongest available link
      between the immune and coagulation arms of this disease.
    evidence:
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "As TAFI and TAFIa are also inhibitors of complement C3a and C5a16, the decrease of total TAFI may be associated with consumption to suppress the activated complement system"
      explanation: >
        PARTIAL - the authors offer this as an interpretation of their own
        measurement ("may be associated with"), not as a demonstrated mechanism.

- name: Pulmonary Mast Cell Degranulation
  biological_scale: CELLULAR
  description: >
    A contested node, retained because the disagreement is itself informative.
    Autopsy immunohistochemistry finds increased pulmonary mast cell numbers in
    fatal amniotic fluid embolism, at levels comparable to anaphylactic deaths and
    far above traumatic controls, with extracellular tryptase indicating
    degranulation. But serum tryptase in living or recently deceased patients is
    inconsistent - normal in some fatal cases, and negative in a controlled series
    that also measured urinary histamine. The honest reading is that mast cell
    degranulation occurs in the lung in fatal cases without being established as
    a driver of the syndrome, and it is certainly not a usable diagnostic marker.
  cell_types:
  - preferred_term: mast cell
    term:
      id: CL:0000097
      label: mast cell
  biological_processes:
  - preferred_term: mast cell degranulation
    term:
      id: GO:0043303
      label: mast cell degranulation
    modifier: INCREASED
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These studies, therefore, highlight that mast cell degranulation occurs in the lungs of AFE fatal cases, whereas it does not occur in other fatal pregnancies."
    explanation: The positive histological evidence, with a pregnancy-matched comparison group.
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "the results obtained were negative for serum tryptase and urinary histamine measurements in women with AFE"
    explanation: >
      The controlled negative series. Recorded as REFUTE and kept on the same
      node as the supporting evidence, because splitting them across nodes would
      hide the contradiction rather than curate it.
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, other reports of AFE cases, in which serum tryptase was detected, gave discordant results to the anaphylactic hypothesis."
    explanation: The review's own summary that the serological arm of the anaphylactic hypothesis is discordant.
  downstream:
  - target: Pulmonary Vasoconstriction and Acute Pulmonary Hypertension
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - anaphylactoid_immune_response
    description: >
      Mast cell mediators are vasoactive and would plausibly contribute to
      pulmonary vasoconstriction, but no cited source demonstrates that step in
      this disease. Typed UNKNOWN deliberately: the alternative was to omit the
      edge and lose the claim, or type it DIRECT and assert a mechanism nobody
      has shown.
    evidence:
    - reference: PMID:25807263
      reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Mast cells have a key role in inflammatory and immediate allergic reactions."
      explanation: >
        Supports only the general vasoactive/inflammatory role of the cell type.
        This is why the edge is UNKNOWN rather than DIRECT.

- name: Mechanical Obstruction of the Maternal Pulmonary Microvasculature
  biological_scale: TISSUE
  description: >
    The alternative arm. Fetal squamous cells, lanugo hairs, vernix and mucin
    lodged in the maternal pulmonary microcirculation, obstructing flow. The
    material is demonstrably there at autopsy; what is contested is whether its
    presence causes the syndrome or merely accompanies it, and its former status
    as a pathognomonic diagnostic criterion has been withdrawn.
  cell_types:
  - preferred_term: blood vessel endothelial cell
    term:
      id: CL:0000071
      label: blood vessel endothelial cell
  evidence:
  - reference: PMID:24888909
    reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"
    explanation: States the obstruction mechanism this node represents, as one of two etiologies recognised by the Japanese registry.
  - reference: PMID:26703453
    reference_title: "Amniotic fluid embolism: an Australian-New Zealand population-based study."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "as a post mortem diagnosis (presence of fetal squames/debris in the pulmonary circulation)"
    explanation: >
      Confirms fetal material in the pulmonary circulation is a recognised
      post-mortem finding. INDIRECT because being a diagnostic criterion is not
      evidence that obstruction is the operative mechanism.
  downstream:
  - target: Pulmonary Vasoconstriction and Acute Pulmonary Hypertension
    causal_link_type: DIRECT
    hypothesis_groups:
    - mechanical_embolic_obstruction
    description: >
      Under this model raised pulmonary vascular resistance is produced by
      physical occlusion of the bed rather than by vasospasm. The two hypotheses
      converge here on the same downstream node, which is why the haemodynamic
      sequence is the same under either account.
    evidence:
    - reference: PMID:24888909
      reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "there were two etiologies of AFE: the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"
      explanation: >
        PARTIAL: the source establishes obstruction of pulmonary microvessels but
        does not itself measure the resulting pulmonary vascular resistance.

- name: Pulmonary Vasoconstriction and Acute Pulmonary Hypertension
  biological_scale: TISSUE
  description: >
    The convergence point of both hypotheses and the first step of the stereotyped
    haemodynamic sequence: pulmonary vascular resistance rises acutely. This is
    the node that makes the ordering of events clinically actionable, because
    everything downstream is right-heart failure before it is left-heart failure.
  biological_processes:
  - preferred_term: vasoconstriction
    term:
      id: GO:0042310
      label: vasoconstriction
    modifier: INCREASED
    temporality: ACUTE
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Available evidence suggests that the hemodynamic response to AFE initially presents with increased pulmonary vascular resistance, and right ventricular failure, followed by left ventricular dysfunction."
    explanation: >
      The single sentence that establishes the whole ordered haemodynamic
      sequence curated in the next three nodes.
  downstream:
  - target: Acute Right Ventricular Failure
    causal_link_type: DIRECT
    description: >
      A pressure load imposed suddenly on a ventricle unadapted to it. The right
      ventricle fails before the left, and in that order.
    evidence:
    - reference: PMID:33345954
      reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "initially presents with increased pulmonary vascular resistance, and right ventricular failure, followed by left ventricular dysfunction"
      explanation: States the sequence from raised pulmonary vascular resistance to right ventricular failure.
  - target: Acute Hypoxaemic Respiratory Failure
    causal_link_type: DIRECT
    description: >
      Loss of effective pulmonary perfusion produces acute hypoxaemia, which
      together with hypotension and coagulopathy forms the diagnostic triad.
    evidence:
    - reference: PMID:28188959
      reference_title: "Amniotic fluid embolism: Pathophysiology from the perspective of pathology."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC), occurring during labor, delivery, or immediately postpartum"
      explanation: Names abrupt hypoxia as a defining feature of the syndrome and its timing.

- name: Acute Right Ventricular Failure
  biological_scale: TISSUE
  description: >
    The right ventricle, acutely pressure-loaded, dilates and fails. This is the
    node with the most direct therapeutic consequence in the entry: it is
    identifiable at the bedside by echocardiography, and identifying it changes
    management, because a failing right ventricle is supported with inotropes,
    pulmonary vasodilators and vasopressors rather than with fluid.
  evidence:
  - reference: PMID:31376394
    reference_title: "Amniotic fluid embolism: principles of early clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle"
    explanation: Establishes right ventricular failure as a discrete, detectable state central to early management.
  downstream:
  - target: Left Ventricular Dysfunction and Cardiovascular Collapse
    causal_link_type: DIRECT
    description: >
      Right ventricular failure is followed by left ventricular dysfunction; the
      registry evidence states the order rather than leaving it to inference.
    evidence:
    - reference: PMID:33345954
      reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "right ventricular failure, followed by left ventricular dysfunction"
      explanation: States the temporal ordering that this edge encodes.

- name: Left Ventricular Dysfunction and Cardiovascular Collapse
  biological_scale: ORGANISM
  description: >
    Systemic circulatory failure - profound hypotension progressing in many cases
    to cardiac arrest. This is the presentation that brings the diagnosis to
    mind, and the reason resuscitation rather than diagnosis is the first action.
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The classic clinical signs of AFE, including peripartum respiratory distress, hypoxia, profound hypotension, cardiovascular collapse, and disseminated intravascular coagulopathy"
    explanation: Names cardiovascular collapse and profound hypotension among the consistent clinical features.
  - reference: PMID:32157417
    reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is characterized by cardiovascular compromise, loss of consciousness or other neurologic symptoms, and coagulopathy."
    explanation: Independent statement of the cardiovascular-neurologic-coagulopathic triad.
  downstream:
  - target: Hypoxic-Ischaemic Maternal Organ Injury
    causal_link_type: DIRECT
    description: >
      Global hypoperfusion during collapse and arrest is what produces the
      neurological injury seen in survivors.
    evidence:
    - reference: PMID:21126320
      reference_title: Amniotic fluid embolism in an Australian population-based cohort.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "survivors were at increased risk of cerebral infarction"
      explanation: Documents ischaemic brain injury as a measured outcome in population-level survivors.
  - target: Fetal Hypoxia Secondary to Maternal Circulatory Failure
    causal_link_type: DIRECT
    description: >
      With the fetus still in utero, maternal circulatory failure is transmitted
      directly to the uteroplacental circulation. This is the two-organism step:
      the lesion is entirely maternal and the injury is fetal.
    evidence:
    - reference: PMID:24402585
      reference_title: Amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "prompt delivery of the mother who has sustained cardiopulmonary arrest is critical for improved newborn outcome"
      explanation: >
        The clinical corollary of this edge: newborn outcome depends on
        removing the fetus from the failing maternal circulation.

- name: Coagulation Activation and Fibrinogen Consumption
  biological_scale: ORGANISM
  conforms_to: "thrombogenesis#Coagulation Cascade Activation and Thrombin-Driven Fibrin Formation"
  description: >
    Systemic activation of coagulation with thrombin generation and consumption of
    fibrinogen. Prothrombin fragment 1+2 - a direct marker of thrombin generation
    - is markedly raised, Clauss fibrinogen falls to very low values and D-dimer
    rises. Disseminated intravascular coagulation is documented in 83-100% of
    reported cases regardless of delivery mode, which makes it a defining arm of
    the syndrome rather than a complication of some presentations.

    This node declares conformance to the thrombogenesis module's coagulation
    cascade node and to no other node in that module - see the discussion on why
    the thrombus-formation node is deliberately not claimed.
  biological_processes:
  - preferred_term: blood coagulation
    term:
      id: GO:0007596
      label: blood coagulation
    modifier: INCREASED
    temporality: ACUTE
  cell_types:
  - preferred_term: platelet
    term:
      id: CL:0000233
      label: platelet
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In all registries and research reports, 83–100% of patients demonstrated laboratory abnormalities or clinical findings consistent with DIC, regardless of mode of delivery."
    explanation: Establishes the coagulopathy as near-universal and independent of delivery mode.
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found that AFE and sPA patients had low platelet counts as well as disturbed coagulation function due to the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"
    explanation: The measured coagulation profile - fibrinogen consumption with raised D-dimer - underlying this node.
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both AFE and sPA were associated with activation of coagulation and massive fibrinolysis"
    explanation: >
      The thrombin-generation half of the finding, and the basis for the
      thrombogenesis module conformance declared on this node.
  downstream:
  - target: Haemostatic Failure and Obstetric Haemorrhage
    causal_link_type: DIRECT
    description: >
      Consumption of fibrinogen and clotting factors leaves the uterus unable to
      achieve haemostasis after delivery.
    evidence:
    - reference: PMID:24888909
      reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the other involves the presence of disseminated intravascular coagulation (DIC) and atonic bleeding"
      explanation: Pairs the coagulopathy with atonic bleeding as the presentation of this arm.

- name: Hyperfibrinolysis Uncoupled from Coagulation Activation
  biological_scale: ORGANISM
  description: >
    The mechanistically distinctive finding of this entry, and the reason
    amniotic fluid embolism coagulopathy is not simply "severe DIC". In a direct
    comparison with severe placental abruption - a disease matched for
    coagulation activation, fibrinogen depletion and D-dimer rise - fibrinolytic
    activation in amniotic fluid embolism was hyperactive and did *not* correlate
    with coagulation activation, whereas in abruption the two were positively
    correlated. Tissue plasminogen activator was higher and total
    thrombin-activatable fibrinolysis inhibitor lower than in either abruption or
    controls. Bedside serial testing shows the same picture from the other side:
    fibrinogen and factor V disproportionately low and D-dimers exorbitant while
    platelets and antithrombin - the markers of pure consumption - are only
    slightly reduced.

    The therapeutic consequence is direct: it is the rationale for early
    antifibrinolytic therapy alongside factor replacement, rather than factor
    replacement alone.
  biological_processes:
  - preferred_term: fibrinolysis
    term:
      id: GO:0042730
      label: fibrinolysis
    modifier: INCREASED
    temporality: ACUTE
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we found that fibrinolysis in AFE showed hyperactivation without correlating to the enhanced coagulation, compared to the significant positive correlation between activated coagulation and hyperfibrinolysis in sPA"
    explanation: >
      The uncoupling itself, established against a disease-matched comparator
      rather than against healthy controls - which is what makes it specific to
      amniotic fluid embolism rather than generic to obstetric DIC.
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The contribution of a significant increase of tPA on producing plasmin in plasma, as well as decrease of TAFI and/or TAFIa may combine to promote fibrinolytic hyperactivity"
    explanation: >
      Names the two measured components - raised tissue plasminogen activator and
      depleted TAFI - proposed to produce the hyperfibrinolytic state.
  - reference: PMID:32157417
    reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Disproportionately low levels of fibrinogen and factor five, and exorbitantly elevated D-dimers were present in all cases, whereas markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced."
    explanation: >
      Independent bedside confirmation, and the sharpest statement of why this is
      not adequately described as consumptive coagulopathy.
  - reference: PMID:32157417
    reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our results support hyperfibrinolysis as contributing factor of AFE-associated coagulopathy."
    explanation: >
      PARTIAL because the authors claim a contributing factor from three cases,
      not an established primary mechanism.
  downstream:
  - target: Haemostatic Failure and Obstetric Haemorrhage
    causal_link_type: DIRECT
    description: >
      Premature lysis of formed clot compounds factor consumption, so bleeding
      continues even where coagulation factors are replaced.
    evidence:
    - reference: PMID:32157417
      reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we, therefore, propose a treatment algorithm which includes early use of tranexamic acid and transfusion of red blood cells and fresh frozen plasma, adding fibrinogen if hemostasis is not readily achieved"
      explanation: >
        The therapeutic inference the authors draw, which presupposes that
        hyperfibrinolysis is contributing to the failure of haemostasis.

- name: Haemostatic Failure and Obstetric Haemorrhage
  biological_scale: ORGANISM
  description: >
    Clinical bleeding, typically atonic postpartum haemorrhage compounded by an
    inability to form stable clot. This is the arm that drives transfusion,
    hysterectomy and much of the non-fatal morbidity, and it is the reason the
    guideline recommendation is to assess clotting status early rather than after
    bleeding is established.
  evidence:
  - reference: PMID:26987420
    reference_title: "Amniotic fluid embolism: diagnosis and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "because coagulopathy may follow cardiovascular collapse with amniotic fluid embolism, we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"
    explanation: Establishes clinical bleeding as an expected consequence requiring pre-emptive management.
  - reference: PMID:26703453
    reference_title: "Amniotic fluid embolism: an Australian-New Zealand population-based study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "18% (n = 6) had a hysterectomy and 85% (n = 28) received a transfusion of blood or blood products"
    explanation: Quantifies the haemorrhagic burden at population level - most patients transfused, nearly a fifth hysterectomised.

- name: Acute Hypoxaemic Respiratory Failure
  biological_scale: ORGANISM
  description: >
    Abrupt hypoxaemia with dyspnoea, cyanosis and in severe cases respiratory
    arrest, frequently progressing to acute respiratory distress syndrome in
    survivors of the initial event. Hypoxia is one of the three cardinal
    diagnostic features alongside hypotension and coagulopathy.
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)"
    explanation: Names the respiratory presentation and its component signs.
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "it is more often related to acute respiratory distress syndrome from obstetric complications"
    explanation: >
      PARTIAL: places amniotic fluid embolism among the obstetric causes of
      maternal ARDS without quantifying its contribution.
  downstream:
  - target: Hypoxic-Ischaemic Maternal Organ Injury
    causal_link_type: DIRECT
    description: >
      Failure of oxygenation compounds the perfusion failure in producing organ
      injury, particularly neurological.
    evidence:
    - reference: PMID:28188959
      reference_title: "Amniotic fluid embolism: Pathophysiology from the perspective of pathology."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy"
      explanation: >
        INDIRECT: the syndrome definition places hypoxia and seizures together
        without asserting that one causes the other.

- name: Hypoxic-Ischaemic Maternal Organ Injury
  biological_scale: ORGANISM
  role: OUTCOME
  description: >
    The end state in survivors: neurological injury from the arrest and
    hypoperfusion, ranging from seizures and coma at presentation to cerebral
    infarction and permanent deficit. Neurologically intact survival, not
    survival, is the meaningful outcome measure in this disease - the two figures
    differ substantially in every registry that reports both.
  evidence:
  - reference: PMID:7726251
    reference_title: "Amniotic fluid embolism: analysis of the national registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal mortality was 61%, with neurologically intact survival seen in 15% of women."
    explanation: >
      The original registry figures, and the clearest demonstration that survival
      and intact survival are different quantities.
  - reference: PMID:21126320
    reference_title: Amniotic fluid embolism in an Australian population-based cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "survivors were at increased risk of cerebral infarction"
    explanation: Population-level evidence of ischaemic brain injury as a survivor outcome.

- name: Fetal Hypoxia Secondary to Maternal Circulatory Failure
  biological_scale: ORGANISM
  role: OUTCOME
  description: >
    Where the fetus is in utero at the time of the event, maternal circulatory
    collapse is transmitted to the uteroplacental circulation and produces acute
    fetal hypoxaemia and acidaemia. The lesion is wholly maternal and the injury
    wholly fetal, which is why the therapeutic response - immediate delivery -
    treats the fetus by separating it from the maternal circulation rather than
    by treating anything in the fetus.
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A total of 30 newborns (51%) born to women with typical AFE had Apgar scores < 7 at 1 minute and were acidemic (mean arterial pH was 6.95)."
    explanation: Quantifies the fetal insult - half of newborns depressed and acidaemic, with a profoundly low mean arterial pH.
  - reference: PMID:7726251
    reference_title: "Amniotic fluid embolism: analysis of the national registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of fetuses in utero at the time of the event, only 39% survived."
    explanation: >
      The historical fetal survival figure, and the reason this node is curated
      separately from the maternal outcome node.

phenotypes:
- category: Cardiovascular
  name: Cardiovascular Collapse and Cardiac Arrest
  description: >
    Sudden profound hypotension proceeding in a large proportion of cases to
    cardiac arrest, in a woman in labour or recently delivered. This is the
    presentation that should put amniotic fluid embolism in the differential.
  phenotype_term:
    preferred_term: Cardiac arrest
    term:
      id: HP:0001695
      label: Cardiac arrest
    temporality: ACUTE
  evidence:
  - reference: PMID:26987420
    reference_title: "Amniotic fluid embolism: diagnosis and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we recommend consideration of amniotic fluid embolism in the differential diagnosis of sudden cardiorespiratory collapse in the laboring or recently delivered woman"
    explanation: Establishes sudden cardiorespiratory collapse in the peripartum window as the presenting phenotype.
  - reference: PMID:26703453
    reference_title: "Amniotic fluid embolism: an Australian-New Zealand population-based study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thirteen (42%) women required cardiopulmonary resuscitation"
    explanation: Quantifies how often the presentation reaches arrest in a population-based series.
- category: Cardiovascular
  name: Profound Hypotension
  description: Acute severe systemic hypotension, one of the cardinal diagnostic features.
  phenotype_term:
    preferred_term: Hypotension
    term:
      id: HP:0002615
      label: Hypotension
    severity: SEVERE
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "acute hypotension and/or cardiac arrest"
    explanation: Names acute hypotension as a defining component of the clinical course.
- category: Respiratory
  name: Acute Hypoxaemia
  description: >
    Abrupt hypoxaemia, one of the three cardinal features required by most
    research case definitions.
  phenotype_term:
    preferred_term: Hypoxemia
    term:
      id: HP:0012418
      label: Hypoxemia
    temporality: ACUTE
  evidence:
  - reference: PMID:28188959
    reference_title: "Amniotic fluid embolism: Pathophysiology from the perspective of pathology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy"
    explanation: Lists abrupt hypoxia first among the defining features.
- category: Respiratory
  name: Dyspnoea
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)"
    explanation: Names dyspnoea as a component of the acute respiratory presentation.
- category: Respiratory
  name: Cyanosis
  phenotype_term:
    preferred_term: Cyanosis
    term:
      id: HP:0000961
      label: Cyanosis
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with dyspnoea, cyanosis and/or respiratory arrest"
    explanation: Names cyanosis among the acute respiratory signs.
- category: Respiratory
  name: Pulmonary Oedema
  description: >
    Reported significantly more frequently among survivors of typical than
    atypical disease, so it tracks severity rather than merely accompanying the
    syndrome.
  phenotype_term:
    preferred_term: Pulmonary edema
    term:
      id: HP:0100598
      label: Pulmonary edema
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both pulmonary edema and maternal neurologic injury were significantly more frequent among survivors of typical AFE"
    explanation: Establishes pulmonary oedema as a measured, severity-tracking feature in the registry.
- category: Hematologic
  name: Disseminated Intravascular Coagulation
  description: >
    Documented in 83-100% of reported cases across registries, independent of
    delivery mode. This is a near-obligate feature rather than a complication of
    some presentations.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Disseminated intravascular coagulation
    term:
      id: HP:0005521
      label: Disseminated intravascular coagulation
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In all registries and research reports, 83–100% of patients demonstrated laboratory abnormalities or clinical findings consistent with DIC, regardless of mode of delivery."
    explanation: >
      Directly quantifies the frequency band. This is the rare case where a
      frequency qualifier has its own quantitative support: 83-100% spans the
      VERY_FREQUENT band (80-99%) and above.
- category: Hematologic
  name: Hypofibrinogenaemia
  description: >
    Fibrinogen falls to very low values - a median Clauss fibrinogen of 0.50 g/L
    in the registry comparison series, against roughly 4 g/L in peripartum
    controls.
  phenotype_term:
    preferred_term: Hypofibrinogenemia
    term:
      id: HP:0011900
      label: Hypofibrinogenemia
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"
    explanation: Documents the fibrinogen depletion this phenotype records.
- category: Hematologic
  name: Thrombocytopenia
  description: >
    Present but characteristically mild relative to the fibrinogen deficit - the
    dissociation that argues against pure consumption as the whole mechanism.
  phenotype_term:
    preferred_term: Thrombocytopenia
    term:
      id: HP:0001873
      label: Thrombocytopenia
  evidence:
  - reference: PMID:32157417
    reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced"
    explanation: >
      Records the platelet change and, importantly, its mildness - which is the
      observation this phenotype exists to preserve.
- category: Obstetric
  name: Postpartum Haemorrhage
  description: >
    Atonic bleeding compounded by the coagulopathy. Most affected women are
    transfused and a substantial minority require hysterectomy.
  phenotype_term:
    preferred_term: Post-partum hemorrhage
    term:
      id: HP:0011891
      label: Post-partum hemorrhage
    severity: SEVERE
  evidence:
  - reference: PMID:24888909
    reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the presence of disseminated intravascular coagulation (DIC) and atonic bleeding"
    explanation: Pairs atonic bleeding with the coagulopathy as the haemorrhagic presentation.
- category: Neurologic
  name: Seizures
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
    temporality: ACUTE
  evidence:
  - reference: PMID:28188959
    reference_title: "Amniotic fluid embolism: Pathophysiology from the perspective of pathology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC)"
    explanation: Names seizures among the defining acute features.
- category: Neurologic
  name: Coma
  phenotype_term:
    preferred_term: Coma
    term:
      id: HP:0001259
      label: Coma
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "coagulopathies (disseminated intravascular coagulation and/or severe hemorrhage), coma and seizures"
    explanation: Names coma among the acute clinical features.
- category: Neurologic
  name: Cerebral Infarction in Survivors
  description: >
    Hypoxic-ischaemic brain injury identified as an elevated risk in survivors at
    population level, and the reason neurologically intact survival is reported
    separately from survival.
  phenotype_term:
    preferred_term: Cerebral infarction
    term:
      id: HP:0002140
      label: Ischemic stroke
  evidence:
  - reference: PMID:21126320
    reference_title: Amniotic fluid embolism in an Australian population-based cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "survivors were at increased risk of cerebral infarction"
    explanation: The population-level survivor outcome this phenotype records.
- category: Respiratory
  name: Respiratory Failure Requiring Ventilatory Support
  phenotype_term:
    preferred_term: Respiratory failure
    term:
      id: HP:0002878
      label: Respiratory failure
    temporality: ACUTE
  evidence:
  - reference: PMID:26703453
    reference_title: "Amniotic fluid embolism: an Australian-New Zealand population-based study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Twenty (61%) were admitted to an Intensive Care Unit (ICU)"
    explanation: >
      Proxy evidence for the intensity of respiratory and circulatory support
      required. Recorded here because the ICU admission rate is the measured
      quantity; the entry does not claim a specific ventilation rate.

treatments:
- name: Immediate High-Quality Cardiopulmonary Resuscitation
  description: >
    Because amniotic fluid embolism usually presents with cardiac arrest, standard
    basic and advanced cardiac life support is the first action - before, not
    after, any attempt at diagnosis.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: resuscitation
    term:
      id: NCIT:C50822
      label: Resuscitation
  target_mechanisms:
  - target: Left Ventricular Dysfunction and Cardiovascular Collapse
    treatment_effect: MODULATES
    description: >
      Mechanical circulatory support sustains perfusion through the collapse; it
      does not act on any upstream step, which is why the effect is MODULATES
      rather than INHIBITS.
    evidence:
    - reference: PMID:26987420
      reference_title: "Amniotic fluid embolism: diagnosis and management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we recommend the provision of immediate high-quality cardiopulmonary resuscitation with standard basic cardiac life support and advanced cardiac life support protocols in patients who develop cardiac arrest associated with amniotic fluid embolism"
      explanation: The graded guideline recommendation for this intervention against this node.
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal treatment is primarily supportive"
    explanation: Establishes that the maternal treatment strategy as a whole is supportive rather than mechanism-directed.
- name: Vasopressor and Inotropic Support Directed at the Failing Right Ventricle
  description: >
    Blood-pressure support with vasopressors, and inotropes plus pulmonary
    vasodilators where echocardiography shows right ventricular failure.
    Volume loading is explicitly deprecated in severe right ventricular
    compromise, which is the practical payoff of curating the haemodynamic
    sequence in the right order.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: noradrenaline
      term:
        id: CHEBI:33569
        label: noradrenaline
    - preferred_term: milrinone
      term:
        id: CHEBI:50693
        label: milrinone
  target_mechanisms:
  - target: Acute Right Ventricular Failure
    treatment_effect: MODULATES
    description: >
      Inotropic support acts on the failing right ventricle specifically, which is
      the node echocardiography identifies.
    evidence:
    - reference: PMID:31376394
      reference_title: "Amniotic fluid embolism: principles of early clinical management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators."
      explanation: Directs inotropes and pulmonary vasodilators specifically at right ventricular failure.
  evidence:
  - reference: PMID:31376394
    reference_title: "Amniotic fluid embolism: principles of early clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise."
    explanation: >
      The negative half of the recommendation - vasopressors rather than fluid -
      which is what makes identifying the right ventricle worth doing.
  - reference: PMID:26987420
    reference_title: "Amniotic fluid embolism: diagnosis and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the use of vasopressors and inotropic agents in the initial management of amniotic fluid embolism. Excessive fluid administration should be avoided"
    explanation: Independent guideline statement of the same recommendation and the same caution against fluid.
- name: Pulmonary Vasodilator Therapy
  description: >
    Inhaled or systemic pulmonary vasodilators to unload the right ventricle by
    reducing pulmonary vascular resistance. This is the one intervention in the
    entry that acts on a node upstream of the collapse rather than supporting the
    patient through it.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: inhaled nitric oxide
      term:
        id: CHEBI:16480
        label: nitric oxide
  target_mechanisms:
  - target: Pulmonary Vasoconstriction and Acute Pulmonary Hypertension
    treatment_effect: INHIBITS
    description: >
      Pulmonary vasodilation opposes the vasoconstriction that initiates the
      haemodynamic sequence.
    evidence:
    - reference: PMID:31376394
      reference_title: "Amniotic fluid embolism: principles of early clinical management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators"
      explanation: >
        Names pulmonary vasodilators as an intervention in this setting. Note the
        source states the recommendation, not a measured reduction in pulmonary
        vascular resistance in this disease.
- name: Haemostatic Resuscitation with Massive Transfusion Protocol
  description: >
    Balanced 1:1:1 replacement of packed red cells, fresh frozen plasma and
    platelets, with cryoprecipitate as needed to hold fibrinogen above roughly
    150-200 mg/dL. Guidelines direct that clotting status be assessed early
    rather than after bleeding is established.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: blood transfusion
    term:
      id: NCIT:C15192
      label: Blood Transfusion
  target_mechanisms:
  - target: Haemostatic Failure and Obstetric Haemorrhage
    treatment_effect: RESTORES
    description: >
      Replacement of consumed factors and platelets restores the capacity to form
      clot; it does not address why they were consumed.
    evidence:
    - reference: PMID:31376394
      reference_title: "Amniotic fluid embolism: principles of early clinical management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Amniotic fluid embolism-related coagulopathy should be managed with hemostatic resuscitation with the use of a 1:1:1 ratio of packed red cells, fresh frozen plasma, and platelets (with cryoprecipitate as needed to maintain a serum fibrinogen of >150-200 mg/dL)."
      explanation: The specific replacement strategy and the fibrinogen target it is titrated to.
  evidence:
  - reference: PMID:26987420
    reference_title: "Amniotic fluid embolism: diagnosis and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"
    explanation: The graded guideline recommendation for early haemostatic assessment and massive transfusion.
- name: Tranexamic Acid
  description: >
    Antifibrinolytic therapy, proposed early in the treatment algorithm on the
    basis that the coagulopathy is hyperfibrinolytic and not purely consumptive.
    This is the one pharmacological intervention in the entry whose rationale
    follows from a specific mechanistic finding rather than from generic
    resuscitation practice - but the supporting evidence is a three-case
    observational series proposing an algorithm, not a trial, and it should be
    read that way.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: tranexamic acid
      term:
        id: CHEBI:48669
        label: tranexamic acid
  target_mechanisms:
  - target: Hyperfibrinolysis Uncoupled from Coagulation Activation
    treatment_effect: INHIBITS
    description: >
      Tranexamic acid inhibits fibrinolysis, which is the node the authors invoke
      to justify placing it early in the algorithm.
    evidence:
    - reference: PMID:32157417
      reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Our results support hyperfibrinolysis as contributing factor of AFE-associated coagulopathy. We, therefore, propose a treatment algorithm which includes early use of tranexamic acid"
      explanation: >
        PARTIAL deliberately. The authors propose the algorithm from their
        mechanistic finding; no outcome trial of tranexamic acid in amniotic
        fluid embolism is cited, so this edge records a rationale, not a
        demonstrated benefit.
- name: Immediate Delivery Following Maternal Cardiac Arrest
  description: >
    Delivery of a fetus at 23 weeks or beyond immediately after maternal cardiac
    arrest. It is directed at the fetus - separating it from a failed maternal
    circulation - and is the only intervention in this entry that treats the
    second organism.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: cesarean section
    term:
      id: NCIT:C46088
      label: Cesarean Section
  target_mechanisms:
  - target: Fetal Hypoxia Secondary to Maternal Circulatory Failure
    treatment_effect: BYPASSES
    description: >
      Delivery does not correct the maternal lesion; it removes the fetus from
      dependence on it. BYPASSES rather than INHIBITS for exactly that reason.
    evidence:
    - reference: PMID:24402585
      reference_title: Amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "prompt delivery of the mother who has sustained cardiopulmonary arrest is critical for improved newborn outcome"
      explanation: States the indication and, specifically, that the benefit is to the newborn.
  evidence:
  - reference: PMID:26987420
    reference_title: "Amniotic fluid embolism: diagnosis and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "following cardiac arrest with amniotic fluid embolism, we recommend immediate delivery in the presence of a fetus ≥23 weeks of gestation"
    explanation: The graded guideline recommendation, including the gestational-age threshold.
- name: Venoarterial Extracorporeal Membrane Oxygenation
  description: >
    Rescue mechanical circulatory support where cardiopulmonary resuscitation is
    prolonged, or ventricular dysfunction after arrest is refractory to medical
    management.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: extracorporeal membrane oxygenation
    term:
      id: NCIT:C171507
      label: Extracorporeal Membrane Oxygenation
  target_mechanisms:
  - target: Left Ventricular Dysfunction and Cardiovascular Collapse
    treatment_effect: BYPASSES
    description: >
      Extracorporeal support substitutes for the failed cardiopulmonary unit
      rather than acting on it.
    evidence:
    - reference: PMID:31376394
      reference_title: "Amniotic fluid embolism: principles of early clinical management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given."
      explanation: States the indication and the refractory-failure context.
- name: Oxygenation and Mechanical Ventilation
  description: Airway control, oxygenation and ventilation as part of initial supportive management.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: mechanical ventilation
    term:
      id: NCIT:C70909
      label: Mechanical Ventilation
  target_mechanisms:
  - target: Acute Hypoxaemic Respiratory Failure
    treatment_effect: MODULATES
    description: Ventilatory support corrects the gas-exchange failure without addressing its cause.
    evidence:
    - reference: PMID:26987420
      reference_title: "Amniotic fluid embolism: diagnosis and management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we recommend the provision of adequate oxygenation and ventilation"
      explanation: The guideline recommendation for ventilatory support in initial management.
- name: C1 Esterase Inhibitor Replacement (investigational)
  description: >
    Not an established therapy. It is included because it is the only
    mechanism-directed candidate in this disease that follows from a measured
    deficit with a severity gradient - C1 esterase inhibitor activity is roughly
    half of control in affected women and lower again in fatal cases - and
    because the registry group that made that measurement proposed it as a
    treatment candidate on that basis. No trial evidence is cited.
  therapeutic_modality: PROTEIN_REPLACEMENT
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Complement Activation and C1 Esterase Inhibitor Consumption
    treatment_effect: RESTORES
    description: >
      Replacement of the consumed inhibitor would restore regulation of the
      classical complement pathway and of the contact system.
    evidence:
    - reference: PMID:24888909
      reference_title: "Amniotic fluid embolism: pathophysiology and new strategies for management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "C1 esterase inhibitor activity in AFE cases was significantly lower than those of normal pregnant women. C1 esterase inhibitor may be a promising candidate of treatment of AFE."
      explanation: >
        PARTIAL, and deliberately not upgraded: "may be a promising candidate"
        is a proposal from an observed deficit, not evidence of therapeutic
        effect.

diagnosis:
- name: Clinical Diagnosis of Exclusion
  description: >
    Amniotic fluid embolism has no confirmatory test. Guidelines explicitly
    recommend against using any specific laboratory test to confirm or refute it,
    and every candidate biomarker studied - zinc coproporphyrin, sialyl Tn
    antigen, serum tryptase, complement C3 and C4 - has failed to prove reliable
    for prediction or diagnosis. The diagnosis is made clinically, from sudden
    cardiorespiratory collapse with coagulopathy in the peripartum window, once
    alternatives are excluded.
  evidence:
  - reference: PMID:26987420
    reference_title: "Amniotic fluid embolism: diagnosis and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we do not recommend the use of any specific diagnostic laboratory test to either confirm or refute the diagnosis of amniotic fluid embolism; at the present time, amniotic fluid embolism remains a clinical diagnosis"
    explanation: The guideline statement that there is no confirmatory test.
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "have been studied and reported, but, to date, none appear reliable in predicting or diagnosing AFE"
    explanation: Records that the candidate biomarker programme has not produced a usable test.
- name: Echocardiographic Identification of Right Ventricular Failure
  description: >
    Not diagnostic of the syndrome, but the key management-directing
    investigation: transthoracic or transoesophageal echocardiography identifies
    the failing right ventricle, which determines whether inotropes, pulmonary
    vasodilators and vasopressors or volume are given.
  evidence:
  - reference: PMID:31376394
    reference_title: "Amniotic fluid embolism: principles of early clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle"
    explanation: States the investigation, its timing, and what it identifies.

differential_diagnoses:
- name: Hypovolaemic shock from postpartum haemorrhage
  description: >
    The single most common alternative diagnosis in cases submitted to the US
    registry as amniotic fluid embolism - 21 of the 27 charts with a definitive
    alternative diagnosis. Distinguishing them matters mechanistically, because
    in haemorrhagic shock the coagulopathy follows the blood loss whereas here it
    accompanies the collapse.
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of the 27 women misclassified as an amniotic fluid embolism with an alternative diagnosis, the most common actual diagnosis was hypovolemic shock secondary to postpartum hemorrhage."
    explanation: Quantifies this as the leading misdiagnosis in a chart-reviewed registry.
- name: Anaesthetic complication
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "followed by anesthetic complications (n = 4, 14.8%) and sepsis-related cardiovascular collapse (n = 2, 7.4%)"
    explanation: Names anaesthetic complication and sepsis as the second and third alternative diagnoses in misclassified cases.
- name: Sepsis-related cardiovascular collapse
  description: >
    Particularly difficult to separate, because the haemodynamic profile of
    amniotic fluid embolism was characterised in the first place by its
    similarity to septic shock.
  evidence:
  - reference: PMID:7726251
    reference_title: "Amniotic fluid embolism: analysis of the national registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical and hemodynamic manifestations were similar to those manifest in anaphylaxis and septic shock."
    explanation: The similarity that makes this differential intrinsically hard.
- name: Severe placental abruption with disseminated intravascular coagulation
  description: >
    Shares fibrinogen depletion, D-dimer elevation and thrombocytopenia. The
    discriminating feature in the one direct comparison is the *coupling* between
    coagulation and fibrinolysis, not the magnitude of either.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both AFE and sPA were associated with activation of coagulation and massive fibrinolysis without significant difference in each plasma maker between the groups."
    explanation: >
      States that the individual coagulation markers do not separate the two
      diseases, which is why the discriminator has to be the correlation
      structure rather than any single value.

discussions:
- discussion_id: controversy_afe_mast_cell_arm
  kind: CONTROVERSY
  status: OPEN
  prompt: >
    Does mast cell degranulation contribute causally to amniotic fluid embolism,
    or is the pulmonary mast cell finding a post-mortem epiphenomenon?
  rationale: >
    The evidence splits cleanly by method rather than by quality. Pulmonary
    immunohistochemistry in fatal cases finds mast cell numbers comparable to
    anaphylactic deaths and far above traumatic controls, with extracellular
    tryptase indicating degranulation, and does not find it in other fatal
    pregnancies. Serological measurement disagrees: serum tryptase has been
    normal in fatal cases, and a controlled series measuring both serum tryptase
    and urinary histamine returned negative. This entry curates both on one node
    with opposing `supports` values rather than picking a side, and types the
    outgoing edge UNKNOWN. The distinction matters practically: if the arm is
    causal, tryptase is a candidate biomarker in a disease that has none.
  attaches_to:
  - pathophysiology#Pulmonary Mast Cell Degranulation
  proposed_experiments:
  - experiment_id: exp_afe_serial_tryptase_registry
    name: Prospectively banked serial tryptase and complement in registry-confirmed cases
    description: >
      Measure serum tryptase, complement components and C1 esterase inhibitor on
      timed samples drawn during the acute event in prospectively enrolled cases
      meeting validated research criteria, with peripartum controls. The existing
      serological studies are retrospective, variably timed, and frequently
      post-mortem - which is a sufficient explanation for the discordance on its
      own, and is exactly the confound a prospective design removes.
  evidence:
  - reference: PMID:25807263
    reference_title: "Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, other reports of AFE cases, in which serum tryptase was detected, gave discordant results to the anaphylactic hypothesis."
    explanation: The review's own acknowledgement that this arm of the evidence is discordant.
- discussion_id: interp_afe_thrombogenesis_conformance_boundary
  kind: INTERPRETATION
  status: RESOLVED
  prompt: >
    Why does this entry conform to the thrombogenesis module at the coagulation
    cascade node but not at the thrombus formation node?
  rationale: >
    The coagulation node conforms straightforwardly: prothrombin fragment 1+2 is
    markedly raised, fibrinogen is consumed and D-dimer rises, which is
    thrombin-driven fibrin formation by any reading. The thrombus formation node
    is deliberately not claimed. In amniotic fluid embolism the fibrin that forms
    is lysed as fast as it is made - fibrinolysis is hyperactive and uncoupled
    from coagulation activation - and the clinical expression is uncontrollable
    haemorrhage requiring transfusion and hysterectomy, not an occlusive
    thrombus. Claiming the thrombus node would assert a pathological structure
    that this disease characteristically fails to form, and would license
    downstream inferences about occlusion and ischaemic tissue injury that the
    evidence does not support. Recorded as RESOLVED rather than OPEN because this
    is a curation decision with a stated rationale, not an unanswered question.
  attaches_to:
  - pathophysiology#Coagulation Activation and Fibrinogen Consumption
  - pathophysiology#Hyperfibrinolysis Uncoupled from Coagulation Activation
  evidence:
  - reference: PMID:32157417
    reference_title: "Amniotic fluid embolism-associated coagulopathy: a single-center observational study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Disproportionately low levels of fibrinogen and factor five, and exorbitantly elevated D-dimers were present in all cases, whereas markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced."
    explanation: >
      The dissociation that justifies the boundary: the profile is lytic rather
      than purely consumptive, and platelets - required for the module's
      fibrin-platelet thrombus - are barely affected.
- discussion_id: gap_afe_no_diagnostic_test
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >
    Can a biomarker distinguish amniotic fluid embolism from the obstetric
    conditions it is confused with, given that every candidate tested so far has
    failed?
  rationale: >
    This gap propagates into everything else in the entry. Without a test the
    case definition is a set of clinical criteria, competing criteria sets do not
    agree with each other, and the resulting cohorts differ enough that incidence
    and mortality estimates are not comparable across studies. Nearly half the
    charts submitted to the US registry as amniotic fluid embolism did not
    survive expert review. A 2024 reappraisal reported that none of its 29 cases
    met the Clark criteria while all met the authors' own - which is a statement
    about the criteria, not about the patients. Until this is closed, every
    epidemiological and mechanistic number in this entry inherits an unquantified
    case-definition error.
  attaches_to:
  - pathophysiology#Abnormal Maternal Proinflammatory Mediator Activation
  proposed_experiments:
  - experiment_id: exp_afe_prospective_biomarker_panel
    name: Prospective multi-analyte panel against expert-adjudicated case status
    description: >
      Evaluate a combined panel - complement components, C1 esterase inhibitor
      activity, tryptase, fibrinolytic markers - in prospectively collected
      peripartum-collapse cases adjudicated by expert chart review against
      published research criteria, with the comparator being the conditions
      amniotic fluid embolism is actually confused with (postpartum haemorrhage,
      sepsis, anaesthetic complication) rather than healthy controls. Single
      analytes have been tested this way and failed; whether a combination
      separates the groups has not been established.
  evidence:
  - reference: PMID:33345954
    reference_title: "Amniotic fluid embolism syndrome: analysis of the Unites States International Registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "our data confirm the frequent misdiagnosis of AFE; almost one-half of patients whose diagnosis was believed to be sufficiently secure to prompt submission to the national registry did not, upon careful review of medical records, have confirmed AFE"
    explanation: Quantifies the magnitude of the case-definition problem in the best-curated available series.
  - reference: PMID:38082418
    reference_title: "Amniotic fluid embolism: a reappraisal."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "None of the cases met Clark's criteria while all met our criteria."
    explanation: >
      A direct demonstration that two published criteria sets can classify the
      same 29 patients in completely opposite ways.
- discussion_id: controversy_afe_risk_factors
  kind: CONTROVERSY
  status: OPEN
  prompt: >
    Are there modifiable obstetric risk factors for amniotic fluid embolism, or
    are the reported associations artefacts of case ascertainment?
  rationale: >
    Large administrative cohorts report reproducible associations - medical
    induction of labour roughly doubling the risk, and raised risk with maternal
    age, caesarean or instrumental delivery, polyhydramnios, cervical laceration
    or uterine rupture, placenta previa or abruption and eclampsia. Chart-reviewed
    registry work reaches the opposite practical conclusion: no risk factor
    justifies modifying obstetric practice, and the disease is unpredictable and
    unpreventable. The two are not straightforwardly reconcilable, and the
    proposed explanation is methodological - administrative datasets are known to
    include substantial numbers of women who did not have the disease, which is
    precisely the population in which induction, caesarean and haemorrhage-related
    codes would cluster. The registry series does independently observe excess
    placenta previa, atopy and in-vitro fertilisation, so this entry does not
    treat all associations as artefact; it declines to convert any of them into a
    mechanism node.
  attaches_to:
  - pathophysiology#Breach of the Maternal-Fetal Physiologic Barrier
  evidence:
  - reference: PMID:17055946
    reference_title: "Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism"
    explanation: The strongest population-level association claim, from a three-million-delivery cohort.
  - reference: PMID:17055946
    reference_title: "Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal age of 35 years or older, caesarean or instrumental vaginal delivery, polyhydramnios, cervical laceration or uterine rupture, placenta previa or abruption, eclampsia, and fetal distress were also associated with an increased risk."
    explanation: The full set of associations reported by the same cohort.
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Data regarding the presence of risk factors for amniotic fluid embolism are inconsistent and contradictory; at present, no putative risk factor has been identified that would justify modification of standard obstetric practice to reduce the risk of this condition."
    explanation: >
      The counter-position, from the author of the original registry. Recorded as
      REFUTE against the risk-factor claim rather than being softened - the
      disagreement is the content of this discussion.
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical series based on population or administrative databases that do not include individual chart review by individuals with expertise in critical care obstetrics are likely to both overestimate the incidence and underestimate the mortality of this condition by the inclusion of women who did not have amniotic fluid embolism."
    explanation: >
      The proposed methodological explanation for the disagreement, and the
      reason the prevalence records in this entry note their ascertainment method.
- discussion_id: interp_afe_misnomer
  kind: INTERPRETATION
  status: OPEN
  prompt: >
    Should the entity continue to be called amniotic fluid embolism when the
    dominant mechanistic account is not embolic?
  rationale: >
    The registry analysis that first characterised the syndrome concluded outright
    that the name is a misnomer, and proposed "anaphylactoid syndrome of
    pregnancy" instead - retained here as a synonym. The name has nonetheless
    persisted for three decades, and MONDO, ICD and every cited guideline use it.
    This is recorded because the name actively misleads: it names the alternative
    hypothesis, not the canonical one, and the historical reliance on pulmonary
    squamous cells as a pathognomonic finding - now identified as a source of
    misdiagnosis - is a direct consequence of taking the name literally.
  attaches_to:
  - pathophysiology#Mechanical Obstruction of the Maternal Pulmonary Microvasculature
  evidence:
  - reference: PMID:7726251
    reference_title: "Amniotic fluid embolism: analysis of the national registry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thus the term amniotic fluid embolism appears to be a misnomer."
    explanation: The source of the misnomer claim.

notes: >
  Curated 2026-08-17 against issue #7837 (obstetric coverage gap). No deep-research
  provider report was generated or consumed for this entry; every claim is sourced
  directly from PubMed-cached abstracts and full texts, and no source is cited that
  was not read.

  Two evidence decisions are worth flagging for reviewers. First, this entry uses
  `supports: REFUTE` twice - once for the negative tryptase/histamine series against
  the mast cell node, and once for the risk-factor counter-position - rather than
  omitting the contradicting evidence or downgrading it to PARTIAL. In both cases
  the disagreement is the substance, and hiding it would leave a cleaner but less
  truthful entry. Second, several edges are typed UNKNOWN or
  INDIRECT_UNKNOWN_INTERMEDIATES where a DIRECT edge would have read better: the
  route from complement activation to pulmonary vasoconstriction, and from mast
  cell degranulation to the same node, are asserted by no cited source.

  Two things were considered and deliberately not curated. There is no
  `environmental:` block: the candidate exposures (induction of labour, caesarean
  delivery) are obstetric interventions rather than ECTO-codeable exposures, and
  the risk-factor evidence is contested - see the risk-factor controversy. And no
  `histopathology:` block is included: fetal squames, lanugo and mucin in the
  maternal pulmonary vasculature are a genuine autopsy finding, but their
  diagnostic use has been explicitly withdrawn, and curating them as
  histopathology would re-privilege exactly the criterion the field abandoned. The
  finding is instead carried on the mechanical-obstruction node inside the
  ALTERNATIVE hypothesis group, where its epistemic status is explicit.

  Module conformance is claimed at one node only
  (`thrombogenesis#Coagulation Cascade Activation and Thrombin-Driven Fibrin
  Formation`); see the conformance-boundary discussion for why the thrombus
  formation node is not claimed.

Ask OpenScientist

OpenScientist Report

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Medical Actions

Diagnosis

Prevalence

Clinical Burden

Differential Diagnoses

Source YAML